<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">106610</article-id><article-id pub-id-type="doi">10.7554/eLife.106610</article-id><article-version article-version-type="publication-state">version of record</article-version><article-categories><subj-group subj-group-type="display-channel"><subject>Review Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group></article-categories><title-group><article-title>Hematopoietic stem and progenitor cells as a reservoir for trained immunity</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Tran</surname><given-names>Brandon T</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-9800-8953</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Jeyanathan</surname><given-names>Vidthiya</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0009-0006-7527-7137</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Cao</surname><given-names>Ruoqiong</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-8100-2136</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Kaufmann</surname><given-names>Eva</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-7965-9200</contrib-id><email>eva.kaufmann@queensu.ca</email><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund7"/><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>King</surname><given-names>Katherine Y</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-5093-6005</contrib-id><email>kyk@bcm.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02pttbw34</institution-id><institution>Department of Pediatrics, Division of Infectious Diseases, and Stem Cells and Regenerative Medicine Center, Baylor College of Medicine and Texas Children’s Hospital</institution></institution-wrap><addr-line><named-content content-type="city">Houston</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02pttbw34</institution-id><institution>Program in Cancer and Cell Biology, Graduate School of Biomedical Sciences, Baylor College of Medicine</institution></institution-wrap><addr-line><named-content content-type="city">Houston</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02y72wh86</institution-id><institution>Department of Biomedical and Molecular Sciences, Queen’s University</institution></institution-wrap><addr-line><named-content content-type="city">Kingston</named-content></addr-line><country>Canada</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02pttbw34</institution-id><institution>Program in Immunology and Microbiology, Graduate School of Biomedical Sciences, Baylor College of Medicine</institution></institution-wrap><addr-line><named-content content-type="city">Houston</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Novakovic</surname><given-names>Boris</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/048fyec77</institution-id><institution>Murdoch Childrens Research Institute</institution></institution-wrap><addr-line><named-content content-type="city">Melbourne</named-content></addr-line><country>Australia</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Taniguchi</surname><given-names>Tadatsugu</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/057zh3y96</institution-id><institution>The University of Tokyo</institution></institution-wrap><addr-line><named-content content-type="city">Tokyo</named-content></addr-line><country>Japan</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date publication-format="electronic" date-type="publication"><day>04</day><month>09</month><year>2025</year></pub-date><volume>14</volume><elocation-id>e106610</elocation-id><history><date date-type="received" iso-8601-date="2025-02-28"><day>28</day><month>02</month><year>2025</year></date><date date-type="accepted" iso-8601-date="2025-08-15"><day>15</day><month>08</month><year>2025</year></date></history><permissions><copyright-statement>© 2025, Tran, Jeyanathan, Cao et al</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>Tran, Jeyanathan, Cao et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-106610-v1.pdf"/><abstract><p>Human and murine studies reveal that innate immune cells are able to mount enhanced responses to pathogens after primary inflammatory exposure. Innate immune memory has been shown to last for months to years, longer than the lifespan of most innate immune cells. Indeed, long-lived hematopoietic stem and progenitor cells (HSPCs) serve as a cellular reservoir for innate immune memory. In this review, we summarize the evidence that innate immune memory is epigenetically encoded in HSPCs, and we consider whether HSPC subpopulations with differentiation bias, cell autonomous epigenetic reprogramming, or both features underlie the phenomenon of central trained immunity. We further profile the significant implications of central trained immunity in stem cell transplant, aging, inflammatory diseases, and vaccination strategies for the future.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>innate immune memory</kwd><kwd>trained immunity</kwd><kwd>hematopoietic stem cells</kwd><kwd>inflammation</kwd><kwd>epigenetics</kwd><kwd>metabolism</kwd><kwd>hematopoietic progenitor cells</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000050</institution-id><institution>National Heart, Lung, and Blood Institute</institution></institution-wrap></funding-source><award-id>T32HL2332</award-id><principal-award-recipient><name><surname>Tran</surname><given-names>Brandon T</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000050</institution-id><institution>National Heart, Lung, and Blood Institute</institution></institution-wrap></funding-source><award-id>F31HL164287</award-id><principal-award-recipient><name><surname>Tran</surname><given-names>Brandon T</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000050</institution-id><institution>National Heart, Lung, and Blood Institute</institution></institution-wrap></funding-source><award-id>R35HL155672</award-id><principal-award-recipient><name><surname>King</surname><given-names>Katherine Y</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000054</institution-id><institution>National Cancer Institute</institution></institution-wrap></funding-source><award-id>P01CA265748</award-id><principal-award-recipient><name><surname>King</surname><given-names>Katherine Y</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution>Banting Research Foundation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Kaufmann</surname><given-names>Eva</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution>CIHR</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Kaufmann</surname><given-names>Eva</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001804</institution-id><institution>Canada Research Chairs</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Kaufmann</surname><given-names>Eva</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection, and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Inflammation supports selection, differentiation bias, and epigenetic reprogramming of hematopoietic stem and progenitor cells to generate innate immune memory.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1"><title>Innate immune memory: a new paradigm in immunology</title><p>‘Trained immunity’, or ‘innate immune memory’, describes the concept that innate immune cells, such as macrophages (<xref ref-type="bibr" rid="bib56">Kaufmann et al., 2018</xref>; <xref ref-type="bibr" rid="bib114">Yao et al., 2018</xref>), neutrophils (<xref ref-type="bibr" rid="bib52">Kalafati et al., 2020</xref>), and NK cells (<xref ref-type="bibr" rid="bib105">Verma et al., 2017</xref>)<bold>,</bold> gain enhanced function after a primary encounter with an immunological stimulus (<xref ref-type="bibr" rid="bib80">Netea et al., 2020</xref>). While adaptive immune memory is achieved by recombination of antigen receptors followed by positive and negative selection, trained immunity is generated through epigenetic modifications and metabolic reprogramming incurred upon inflammatory stimulation (<xref ref-type="bibr" rid="bib90">Quintin et al., 2012</xref>; <xref ref-type="bibr" rid="bib27">Cirovic et al., 2020</xref>). Trained immunity can be induced through a variety of infections, vaccines, and adjuvants such as Bacillus Calmette–Guérin (BCG) and the fungal cell wall component beta glucan (β-glucan), or inflammatory stimuli released during autoimmune diseases. Trained immunity initiated by these stimuli can enhance cross-protective host immunity against infections or cancer (<xref ref-type="bibr" rid="bib52">Kalafati et al., 2020</xref>; <xref ref-type="bibr" rid="bib44">Hersh et al., 1977</xref>; <xref ref-type="bibr" rid="bib104">van Puffelen et al., 2020</xref>; <xref ref-type="bibr" rid="bib63">Larsen et al., 2020b</xref>; <xref ref-type="bibr" rid="bib71">Mills et al., 2024</xref>; <xref ref-type="bibr" rid="bib107">Walk et al., 2020</xref>). Innate immune memory has also been associated with maladaptive effects such as periodontitis, arthritis, and long COVID (<xref ref-type="bibr" rid="bib22">Cheong et al., 2023</xref>; <xref ref-type="bibr" rid="bib23">Christ et al., 2018</xref>, <xref ref-type="bibr" rid="bib65">Li et al., 2022</xref>). Indeed, some attempts to use trained immunity to protect against infection have resulted in counterproductive hyperinflammation (<xref ref-type="bibr" rid="bib106">Walk et al., 2019</xref>). Thus, while trained immunity can serve as a powerful tool to improve host immunity, it also has the capacity to confer a detrimental burden on patient health.</p><p>In humans, trained immunity after BCG vaccination was found to last for over 1 year in circulating monocytes (<xref ref-type="bibr" rid="bib61">Kleinnijenhuis et al., 2014</xref>). These long-term effects were surprising since circulating monocytes have a half-life of only a few days in humans and mice (<xref ref-type="bibr" rid="bib86">Patel et al., 2017</xref>; <xref ref-type="bibr" rid="bib103">Teh et al., 2019</xref>). As circulating innate immune cells lack self-renewal capacity and are primarily short-lived, investigators have turned to hematopoietic stem and progenitor cells (HSPCs), the long-lived and self-renewing progenitors of innate immune cells (see <xref ref-type="box" rid="box1">Box 1</xref>), as the potential reservoir for trained immunity (<xref ref-type="bibr" rid="bib85">Orkin and Zon, 2008</xref>). Possessing both multilineage differentiation potential and self-renewal capacity, HSPCs are known to respond to environmental cues such as inflammation triggered by infection, diet, or aging (<xref ref-type="bibr" rid="bib60">King and Goodell, 2011</xref>; <xref ref-type="bibr" rid="bib101">Takizawa et al., 2012</xref>; <xref ref-type="bibr" rid="bib89">Pietras, 2017</xref>; <xref ref-type="bibr" rid="bib31">Ding et al., 2021</xref>). Indeed, HSPCs express Toll-like receptors and other pathogen-associated molecular pattern recognition and cytokine receptors that equip them to detect and respond to inflammatory stimuli. Upon detection of external stressors, HSPCs undergo emergency myelopoiesis, thereby directly contributing to the immune response (<xref ref-type="bibr" rid="bib15">Cao et al., 2024</xref>).</p><boxed-text id="box1"><label>Box 1.</label><caption><title>Hematopoietic stem and progenitor cell (HSPC) subsets.</title></caption><p>HSPCs are composed of a heterogeneous pool of stem and progenitor cells, each with varying capacity for multipotency and self-renewal. HSPCs include long-term HSCs (LT-HSCs), short-term HSCs (ST-HSCs), multipotent progenitors (MPPs), common myeloid progenitors (CMPs), megakaryocyte–erythrocyte progenitors (MEP), granulocyte–monocyte progenitors (GMPs), and common lymphoid progenitors (CLPs) (<xref ref-type="fig" rid="fig1">Figure 1</xref>). While cell types are ultimately defined by their functional properties, they are often phenotypically characterized by cell surface marker expression.</p><p>LSK cells and lineage-committed progenitors compose the lineage-negative population, indicating the absence of lineage-specific markers on fully differentiated cells, such as myeloid and lymphoid cells. LT-HSCs are the most primitive HSCs, retaining the capability to self-renew over an individual’s entire lifespan. LT-HSCs were first characterized through studies that demonstrated their ability to regenerate the bone marrow of irradiated mice over an extended period of time (<xref ref-type="bibr" rid="bib79">Nakauchi et al., 1999</xref>). The widely used surface markers associated with this cell population are Lin<sup>−</sup>Sca1<sup>+</sup>c-Kit<sup>+</sup>CD34<sup>−</sup>CD150<sup>+</sup>CD48<sup>−</sup>Flt3<sup>−</sup> (<xref ref-type="bibr" rid="bib79">Nakauchi et al., 1999</xref>; <xref ref-type="bibr" rid="bib112">Yang et al., 2005</xref>; <xref ref-type="bibr" rid="bib16">Challen et al., 2009</xref>; <xref ref-type="bibr" rid="bib91">Rathinam et al., 2011</xref>; <xref ref-type="bibr" rid="bib108">Wang et al., 2013</xref>; <xref ref-type="bibr" rid="bib9">Belle et al., 2016</xref>). ST-HSCs derive from LT-HSCs but lack the high self-renewal capacity of their upstream precursors. Despite this, they retain their multipotency and act as the primary source of key effector cells that execute the rapid and robust response central to trained immunity and contribute to hematopoiesis over the span of weeks to months (<xref ref-type="bibr" rid="bib16">Challen et al., 2009</xref>). ST-HSCs share many surface markers with LT-HSCs, albeit with subtle differences. In mice, ST-HSCs are typically Lin<sup>−</sup>Sca1<sup>+</sup>c-Kit<sup>+</sup>CD34<sup>+</sup>CD150<sup>+</sup>CD48<sup>+</sup>Flt3<sup>−</sup> (<xref ref-type="bibr" rid="bib79">Nakauchi et al., 1999</xref>; <xref ref-type="bibr" rid="bib112">Yang et al., 2005</xref>; <xref ref-type="bibr" rid="bib16">Challen et al., 2009</xref>; <xref ref-type="bibr" rid="bib91">Rathinam et al., 2011</xref>; <xref ref-type="bibr" rid="bib108">Wang et al., 2013</xref>; <xref ref-type="bibr" rid="bib9">Belle et al., 2016</xref>).</p><p>MPPs are downstream of LT-HSCs and ST-HSCs but are still considered LSK cells. They give rise to all major blood cell lineages, including erythroid, myeloid, and lymphoid cells. Phenotypically, they are similar to ST-HSCs (<xref ref-type="bibr" rid="bib112">Yang et al., 2005</xref>; <xref ref-type="bibr" rid="bib108">Wang et al., 2013</xref>). These cells are critical bridges between HSCs and lineage-committed progenitors and can be further differentiated into distinct subpopulations. MPP1s are highly similar to LT-HSCs, but metabolically more active and have self-renewal capacity. They are primarily biased toward lymphoid and myeloid lineages and are typically marked by CD150<sup>+</sup>CD48<sup>−</sup>CD34<sup>+</sup>Flt3<sup>−</sup> surface expression (<xref ref-type="bibr" rid="bib88">Pietras et al., 2015</xref>; <xref ref-type="bibr" rid="bib91">Rathinam et al., 2011</xref>; <xref ref-type="bibr" rid="bib108">Wang et al., 2013</xref>; <xref ref-type="bibr" rid="bib9">Belle et al., 2016</xref>; <xref ref-type="bibr" rid="bib110">Wilson et al., 2008</xref>; <xref ref-type="bibr" rid="bib14">Cabezas-Wallscheid et al., 2014</xref>). MPP2s are more restricted than MPP1s and are biased toward differentiation into megakaryocytes and erythrocytes. This subset is marked by CD150<sup>+</sup>CD48<sup>+</sup>CD34<sup>+</sup>Flt3<sup>−</sup> surface expression (<xref ref-type="bibr" rid="bib91">Rathinam et al., 2011</xref>; <xref ref-type="bibr" rid="bib108">Wang et al., 2013</xref>; <xref ref-type="bibr" rid="bib9">Belle et al., 2016</xref>; <xref ref-type="bibr" rid="bib110">Wilson et al., 2008</xref>; <xref ref-type="bibr" rid="bib14">Cabezas-Wallscheid et al., 2014</xref>). MPP3s give rise to myeloid cells, with a bias toward granulocytes and monocytes. These cells are characterized by CD150<sup>−</sup>CD48<sup>+</sup>CD34<sup>+</sup>Flt3<sup>−</sup> surface expression (<xref ref-type="bibr" rid="bib91">Rathinam et al., 2011</xref>; <xref ref-type="bibr" rid="bib108">Wang et al., 2013</xref>; <xref ref-type="bibr" rid="bib9">Belle et al., 2016</xref>; <xref ref-type="bibr" rid="bib110">Wilson et al., 2008</xref>; <xref ref-type="bibr" rid="bib14">Cabezas-Wallscheid et al., 2014</xref>). MPP4s are primarily lymphoid-biased and are typically marked by CD150<sup>−</sup>CD48<sup>+</sup>CD34<sup>+</sup>Flt3<sup>+</sup> surface expression (<xref ref-type="bibr" rid="bib91">Rathinam et al., 2011</xref>; <xref ref-type="bibr" rid="bib108">Wang et al., 2013</xref>; <xref ref-type="bibr" rid="bib9">Belle et al., 2016</xref>; <xref ref-type="bibr" rid="bib110">Wilson et al., 2008</xref>; <xref ref-type="bibr" rid="bib14">Cabezas-Wallscheid et al., 2014</xref>).</p><p>The identification and isolation of HSCs are in most part dependent on their surface marker expression, but the inconsistent use of surface markers in categorizing different HSC subsets sparks debate. For instance, some authors label ST-HSCs as positive for CD150 and CD48 (<xref ref-type="bibr" rid="bib91">Rathinam et al., 2011</xref>; <xref ref-type="bibr" rid="bib108">Wang et al., 2013</xref>), whereas others label them as negative for those surface markers (<xref ref-type="bibr" rid="bib88">Pietras et al., 2015</xref>; <xref ref-type="bibr" rid="bib95">Sawai et al., 2016</xref>). Differences in experimental models, such as mouse strains, method of isolation (flow cytometry versus magnetic bead separation), age of the cells, or physiological state of the organism complicate the unification of defining HSCs, potentially through up- and downregulation of surface marker expression (<xref ref-type="bibr" rid="bib76">Morrison and Scadden, 2014</xref>). Nevertheless, the consensus paper published in 2021 by Challen et al. brings together most of these markers and categories (<xref ref-type="bibr" rid="bib17">Challen et al., 2021</xref>). Further marker description will enhance the potential to discriminate different subpopulations. In light of discrepancies in the field, naming of all markers for definition of certain populations remains of significant importance for ongoing use and extrapolation of experimental results. Coming to a consensus as well as incorporating functional assays for identification of these cell populations will ultimately be crucial for ongoing HSC research and its clinical applications.</p><p>Markers of HSPCs differ substantially between mice and humans. Human HSCs are defined by the cell surface markers CD34<sup>+</sup>CD38<sup>−</sup>CD90<sup>+</sup>CD45RA<sup>−</sup> (<xref ref-type="bibr" rid="bib26">Cimato et al., 2016</xref>). Unlike their mouse counterparts, the nomenclature of human HSCs is less debated due to consistent identification of surface markers, which remain mostly stable, and functional assays utilized in human studies (<xref ref-type="bibr" rid="bib4">Anjos-Afonso and Bonnet, 2023</xref>). Human LT-HSCs are classified as Lin<sup>−</sup>CD34<sup>+</sup>CD38<sup>−</sup>CD90<sup>+</sup>CD45RA<sup>−</sup>CD49f<sup>+</sup>, which give rise to ST-HSCs that express Lin<sup>−</sup>CD34<sup>+</sup>CD38<sup>−</sup>CD90<sup>−</sup>CD45RA<sup>−</sup>CD49f<sup>−</sup> (<xref ref-type="bibr" rid="bib93">Rix et al., 2022</xref>). MPP-F1 (CD34<sup>+</sup>CD38<sup>−</sup>CD90<sup>−</sup>CD45RA<sup>−</sup>CD71<sup>−</sup>CD110<sup>−</sup>) and MPP-F2/3 (CD34<sup>+</sup>CD38<sup>−</sup>CD90<sup>−</sup>CD45RA<sup>−</sup>CD71<sup>+</sup>) are three cellular fractions that derive from ST-HSCs, of which the former retain greater multilineage differentiation potential (<xref ref-type="bibr" rid="bib81">Notta et al., 2016</xref>).</p></boxed-text><p>The potential for HSPCs to serve as a memory reservoir for trained immunity has been described in both murine (<xref ref-type="bibr" rid="bib56">Kaufmann et al., 2018</xref>; <xref ref-type="bibr" rid="bib71">Mills et al., 2024</xref>; <xref ref-type="bibr" rid="bib73">Mitroulis et al., 2018</xref>; <xref ref-type="bibr" rid="bib58">Khan et al., 2020</xref>; <xref ref-type="bibr" rid="bib51">Kain et al., 2023</xref>; <xref ref-type="bibr" rid="bib118">Zhu et al., 2024</xref>; <xref ref-type="bibr" rid="bib52">Kalafati et al., 2020</xref>; <xref ref-type="bibr" rid="bib30">de Laval et al., 2020</xref>; <xref ref-type="table" rid="table1">Table 1</xref>) and human studies (<xref ref-type="bibr" rid="bib27">Cirovic et al., 2020</xref>; <xref ref-type="bibr" rid="bib22">Cheong et al., 2023</xref>; <xref ref-type="bibr" rid="bib100">Sun et al., 2024</xref>). Experiments in which memory phenotypes were transferred via HSPCs from trained donors into irradiated recipients have demonstrated the sufficiency of reprogrammed HSPCs to generate innate immune memory in circulating immune cells (<xref ref-type="bibr" rid="bib56">Kaufmann et al., 2018</xref>; <xref ref-type="bibr" rid="bib73">Mitroulis et al., 2018</xref>; <xref ref-type="bibr" rid="bib58">Khan et al., 2020</xref>; <xref ref-type="bibr" rid="bib51">Kain et al., 2023</xref>; <xref ref-type="bibr" rid="bib30">de Laval et al., 2020</xref>). Long-term reprogramming has been observed in mouse studies of hemozoin-dependent <italic>Plasmodium</italic> infection (<xref ref-type="bibr" rid="bib118">Zhu et al., 2024</xref>) and in longitudinal studies in humans trained with BCG vaccination (<xref ref-type="bibr" rid="bib27">Cirovic et al., 2020</xref>; <xref ref-type="bibr" rid="bib100">Sun et al., 2024</xref>) or long COVID (<xref ref-type="bibr" rid="bib22">Cheong et al., 2023</xref>). Notably, innate immune memory has also been observed in non-immune cells, such as epidermal stem cells (<xref ref-type="bibr" rid="bib78">Naik and Fuchs, 2022</xref>; <xref ref-type="bibr" rid="bib62">Larsen et al., 2020a</xref>) and embryonic fibroblasts (<xref ref-type="bibr" rid="bib53">Kamada et al., 2018</xref>). Like immune cells, these structural cells exhibit heightened transcriptional responses following an initial training period of inflammatory exposure and recovery. A common theme is that cells harboring ‘memory’ must either be self-renewing, long-lived, or both. At the very least, these cells must be able to survive the initial insult for the reprogramming to persist.</p><table-wrap id="table1" position="float"><label>Table 1.</label><caption><title>Hematopoietic stem and progenitor cell (HSPC) populations mediating trained immunity phenotypes.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Cell type</th><th align="left" valign="bottom">TI experimental endpoint</th><th align="left" valign="bottom">Inducing stimulus</th><th align="left" valign="bottom">TI phenotype</th><th align="left" valign="bottom">Citations</th></tr></thead><tbody><tr><td align="left" valign="bottom" rowspan="2">Whole bone marrow</td><td align="char" char="." valign="bottom">20 weeks</td><td align="left" valign="bottom">BCG</td><td align="left" valign="bottom">Protection from <italic>M. tb</italic> infection</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib56">Kaufmann et al., 2018</xref></td></tr><tr><td align="char" char="." valign="bottom">1 year</td><td align="left" valign="bottom"><italic>M. tb</italic></td><td align="left" valign="bottom">Susceptibility to <italic>M. tb</italic></td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib58">Khan et al., 2020</xref></td></tr><tr><td align="left" valign="bottom" rowspan="2">cKit enriched</td><td align="left" valign="bottom" rowspan="2">16 weeks to &gt;1 year</td><td align="left" valign="bottom"><italic>M. avium</italic></td><td align="left" valign="bottom" rowspan="2">Cross protection</td><td align="char" char="." valign="bottom" rowspan="2"><xref ref-type="bibr" rid="bib51">Kain et al., 2023</xref></td></tr><tr><td align="left" valign="bottom">H1N1</td></tr><tr><td align="left" valign="bottom">LSK</td><td align="left" valign="bottom">13 weeks and secondary transplant</td><td align="left" valign="bottom">LPS</td><td align="left" valign="bottom">Protection from <italic>P. aeruginosa</italic></td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib30">de Laval et al., 2020</xref></td></tr><tr><td align="left" valign="bottom" rowspan="3">LT-HSC</td><td align="left" valign="bottom">13 weeks and secondary transplant</td><td align="left" valign="bottom">LPS</td><td align="left" valign="bottom">Protection from <italic>P. aeruginosa</italic></td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib30">de Laval et al., 2020</xref></td></tr><tr><td align="char" char="." valign="bottom">8 months</td><td align="left" valign="bottom"><italic>Fasciola hepatica</italic> excretory–secretory products (FHES)</td><td align="left" valign="bottom">Reduced susceptibility to induction of EAE</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib29">Cunningham et al., 2021</xref></td></tr><tr><td align="char" char="." valign="bottom">1 year</td><td align="left" valign="bottom"><italic>M. tb</italic></td><td align="left" valign="bottom">Inhibit trained immunity</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib58">Khan et al., 2020</xref></td></tr><tr><td align="left" valign="bottom" rowspan="4">ST-HSC/MPP3</td><td align="char" char="." valign="bottom" rowspan="4">4 weeks</td><td align="left" valign="bottom">BCG</td><td align="left" valign="bottom">↑ ST-HSC, MPP3</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib56">Kaufmann et al., 2018</xref></td></tr><tr><td align="left" valign="bottom"><italic>M. tb</italic></td><td align="left" valign="bottom">↓ ST-HSC, MPP3</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib58">Khan et al., 2020</xref></td></tr><tr><td align="left" valign="bottom">Heme</td><td align="left" valign="bottom">↑ ST-HSC, MPP3</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib49">Jentho et al., 2021</xref></td></tr><tr><td align="left" valign="bottom">Western diet</td><td align="left" valign="bottom">↓ MPPs</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib23">Christ et al., 2018</xref></td></tr><tr><td align="left" valign="bottom" rowspan="3">GMPs</td><td align="char" char="." valign="bottom">1 week</td><td align="left" valign="bottom">β-Glucan</td><td align="left" valign="bottom">Anti-tumor immunity</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib52">Kalafati et al., 2020</xref></td></tr><tr><td align="char" char="." valign="bottom">1 year</td><td align="left" valign="bottom">COVID</td><td align="left" valign="bottom">Long-term inflammation</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib22">Cheong et al., 2023</xref></td></tr><tr><td align="char" char="." valign="bottom">12 weeks</td><td align="left" valign="bottom">Sepsis</td><td align="left" valign="bottom">Post-sepsis immunosuppression</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib11">Bomans et al., 2018</xref></td></tr></tbody></table></table-wrap><p>The mechanism by which HSPCs encode memory is the subject of intense investigation. Recent studies indicate two key findings: (1) inflammatory responses by HSPCs in the bone marrow are highly heterogeneous (<xref ref-type="bibr" rid="bib51">Kain et al., 2023</xref>; <xref ref-type="bibr" rid="bib6">Arts et al., 2018</xref>) and (2) epigenetic changes in response to infection affect HSPC quiescence and differentiation (<xref ref-type="bibr" rid="bib100">Sun et al., 2024</xref>; <xref ref-type="bibr" rid="bib30">de Laval et al., 2020</xref>; <xref ref-type="bibr" rid="bib47">Hormaechea-Agulla et al., 2021</xref>). These observations raise the potential that inflammatory stimuli can affect innate immune function via selective activation, involving proliferation and differentiation, and epigenetic reprogramming of HSPC subsets, thereby influencing lineage fate determination and reshaping immune cell populations (<xref ref-type="bibr" rid="bib50">Johansson et al., 2023</xref>).</p><p>Overall, the concept that HSPCs in the bone marrow, where 90% of HSPCs are found, are a long-term reservoir for innate immune memory is termed ‘central trained immunity’ to distinguish it from reprogramming in peripheral cell populations (<xref ref-type="bibr" rid="bib80">Netea et al., 2020</xref>; <xref ref-type="bibr" rid="bib70">Mende and Laurenti, 2021</xref>). In this review, we focus on the emerging evidence and mechanisms by which HSPCs encode long-term innate immune memory.</p></sec><sec id="s2"><title>Investigating the role of hematopoietic stem cells in central trained immunity</title><p>Hematopoietic stem cells (HSCs) are the adult stem cells responsible for lifelong production of blood, including immune cells. HSCs are positioned at the apex of the hematopoietic hierarchy and possess the highest multipotency and self-renewal potential (<xref ref-type="fig" rid="fig1">Figure 1</xref>, see <xref ref-type="box" rid="box1">Box 1</xref>). Transcriptional studies have demonstrated that inflammation promotes differentiation and loss of self-renewal potential of HSCs (<xref ref-type="bibr" rid="bib89">Pietras, 2017</xref>; <xref ref-type="bibr" rid="bib68">Matatall et al., 2014</xref>; <xref ref-type="bibr" rid="bib8">Baldridge et al., 2010</xref>), leading to their eventual exhaustion (<xref ref-type="bibr" rid="bib69">Matatall et al., 2016</xref>). Like monocytes and macrophages, HSCs express receptors for inflammatory cytokines and pathogen-associated molecular patterns such as LPS (<xref ref-type="bibr" rid="bib8">Baldridge et al., 2010</xref>; <xref ref-type="bibr" rid="bib77">Nagai et al., 2006</xref>; <xref ref-type="bibr" rid="bib34">Essers et al., 2009</xref>). They can directly respond to these stimuli by producing more inflammatory cytokines, activating downstream inflammatory response pathways such as JAK–STAT signaling, and shifting metabolic pathways through mTOR signaling (<xref ref-type="bibr" rid="bib20">Cheng et al., 2014</xref>; <xref ref-type="bibr" rid="bib71">Mills et al., 2024</xref>; <xref ref-type="bibr" rid="bib51">Kain et al., 2023</xref>; <xref ref-type="bibr" rid="bib8">Baldridge et al., 2010</xref>). Notably, innate immune function responses like antigen presentation, specifically of MHC class II genes like <italic>H2-Ab1</italic>, can be observed in HSCs in several contexts including <italic>M. avium</italic> infection (<xref ref-type="bibr" rid="bib47">Hormaechea-Agulla et al., 2021</xref>), LPS stimulation (<xref ref-type="bibr" rid="bib43">Hernández-Malmierca et al., 2022</xref>), and autoimmune disease models mimicking systemic lupus erythematosus (<xref ref-type="bibr" rid="bib71">Mills et al., 2024</xref>). Thus, despite their disparate position in the hematopoietic hierarchy, HSCs and innate immune cells share many common biological processes. This observation raises the possibility that inflammatory stimuli activate and reprogram transcription networks that are directly passed down to trained immune cell progeny.</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Hierarchical model of hematopoiesis.</title><p>Hematopoiesis is often depicted as a linear cell fate tree; however, recent investigation has shown developmental relationships between the various hematopoietic lineages. The LKS cell population comprises long-term hematopoietic stem cells (LT-HSCs), short-term HSCs (ST-HSCs), and multipotent progenitors (MPPs) in various stages. HSCs give rise to MPPs, with MPP1 representing early multipotent progenitors that are a metabolically active form of the most quiescent HSCs with the capacity for multi-lineage potential. Further downstream are specific multipotent progenitors (MPPs) which give rise to lineage-committed progenitors that are restricted in their differentiation potentials. MPP2 is biased to give rise to megakaryocyte–erythrocyte progenitors (MEPs), MPP3 to granulocyte–monocyte progenitors (GMPs), and MPP4 to common lymphoid progenitors (CLPs). While each of these multipotent progenitors is biased toward the production of specific lineage-committed progenitors, they can be skewed to favor the expansion of others, depending on the nature of the bone marrow microenvironment and timing of an insult. Lineage-committed progenitors develop into mature blood cells: MEP into platelets and erythrocytes, GMP into monocytes, basophils, neutrophils, and eosinophils, and CLP into pre-NK cells, pre-B cells, and thymocytes.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-106610-fig1-v1.tif"/></fig><p>Methods to study HSC function have been developed over several decades. HSC transplantation studies in mice have been used to functionally define HSCs and study their role in various contexts, including trained immunity (<xref ref-type="bibr" rid="bib56">Kaufmann et al., 2018</xref>; <xref ref-type="bibr" rid="bib73">Mitroulis et al., 2018</xref>; <xref ref-type="bibr" rid="bib88">Pietras et al., 2015</xref>; <xref ref-type="bibr" rid="bib82">Ochando et al., 2023</xref>). While many different transplant strategies exist (<xref ref-type="bibr" rid="bib55">Kang et al., 2024</xref>; <xref ref-type="bibr" rid="bib115">Yeung et al., 2024</xref>; <xref ref-type="bibr" rid="bib18">Chanut et al., 2021</xref>), the most common ones use whole body irradiation to ablate fast cycling cells, clear the hematopoietic niche, and allow for successful engraftment of donor HSPCs. Donor HSPCs injected intravenously home to the bone marrow and produce blood for a period of time that is proportionate to their self-renewal potential (<xref ref-type="bibr" rid="bib88">Pietras et al., 2015</xref>; <xref ref-type="bibr" rid="bib3">Al-Amoodi et al., 2022</xref>). Multipotent progenitors and committed myeloid progenitors can produce blood, particularly myeloid cells, for up to several weeks, whereas long-term engraftment beyond 3 months is maintained by long-term HSCs (LT-HSCs) (<xref ref-type="bibr" rid="bib96">Säwen et al., 2018</xref>; <xref ref-type="bibr" rid="bib84">Oguro et al., 2013</xref>; <xref ref-type="bibr" rid="bib98">Spangrude et al., 1988</xref>; <xref ref-type="fig" rid="fig2">Figure 2</xref>). This observation has led some to conclude that LT-HSCs must be the reservoir for long-term central trained immunity; however, our own work transplanting <italic>M. avium</italic>-trained LT-HSCs suggests LT-HSCs alone cannot confer central trained immunity-mediated host protection (<xref ref-type="bibr" rid="bib51">Kain et al., 2023</xref>). In addition, studies of native hematopoiesis in the absence of transplantation have indicated a significant long-term contribution of multipotent progenitors to hematopoiesis (<xref ref-type="bibr" rid="bib99">Sun et al., 2014</xref>; <xref ref-type="bibr" rid="bib13">Busch and Rodewald, 2016</xref>; <xref ref-type="bibr" rid="bib87">Pei et al., 2017</xref>; <xref ref-type="bibr" rid="bib21">Cheng et al., 2020</xref>). This raises the possibility that multipotent progenitors may play a key role in central trained immunity. New <italic>in vitro</italic> culture methods like polyvinyl alcohol culturing of HSCs and/or downstream progenitors will enable researchers to assess the durability and relevance of epigenetic reprogramming in specific HSPC subpopulations (<xref ref-type="bibr" rid="bib109">Wilkinson et al., 2019</xref>).</p><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>The engraftment potential of hematopoietic stem and progenitor cell (HSPC) subpopulations in transplant mouse models.</title><p>Murine transplant studies have been used to determine engraftment capacity of hematopoietic cells. Whole bone marrow (black line) can be transplanted into irradiated recipients to fully reestablish the hematopoietic system. Myeloid cells such as neutrophils and macrophages are the first to develop in the first few weeks post-transplantation, followed by lymphoid cells (<xref ref-type="bibr" rid="bib88">Pietras et al., 2015</xref>; <xref ref-type="bibr" rid="bib83">Ogonek et al., 2016</xref>). Hematopoietic stem cells (HSCs) are considered the main contributors to the long-term engraftment observed in hematopoietic transplant models. A single HSC (blue) can reconstitute the mouse hematopoietic system and can be serially transplanted for continued long-term hematopoiesis (<xref ref-type="bibr" rid="bib88">Pietras et al., 2015</xref>; <xref ref-type="bibr" rid="bib84">Oguro et al., 2013</xref>; <xref ref-type="bibr" rid="bib98">Spangrude et al., 1988</xref>). Unlike HSCs and whole bone marrow, myeloid-biased downstream progenitors, such as multipotent progenitors (MPPs) (red), have been reported to sustain multilineage hematopoiesis for 4 weeks before their exhaustion and disappearance (<xref ref-type="bibr" rid="bib88">Pietras et al., 2015</xref>; <xref ref-type="bibr" rid="bib84">Oguro et al., 2013</xref>). The persistence of granulocyte–monocyte progenitors (GMPs) alone is even shorter compared to MPP3s (labeled in dashed green) (<xref ref-type="bibr" rid="bib88">Pietras et al., 2015</xref>; <xref ref-type="bibr" rid="bib96">Säwen et al., 2018</xref>). Of note, barcoding studies have shown much longer multilineage hematopoiesis from MPPs and GMPs in native, non-transplant conditions (<xref ref-type="bibr" rid="bib97">Shaban et al., 2025</xref>).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-106610-fig2-v1.tif"/></fig><sec id="s2-1"><title>Investigating central trained immunity in transplantation settings</title><p>In the first study to investigate the role of HSPCs in central trained immunity, we showed that reprogrammed HSPCs provide improved, non-specific host immunity to recipient mice. Specifically, transplant of whole bone marrow from BCG iv-vaccinated mice provided immunity against subsequent <italic>Mycobacterium tuberculosis</italic> (<italic>M. tb</italic>) challenge 14 weeks post-transplant (<xref ref-type="bibr" rid="bib56">Kaufmann et al., 2018</xref>). Further refinement of transplant studies, such as transplanting lineage-negative, cKit+, Sca1+ cells (<xref ref-type="bibr" rid="bib30">de Laval et al., 2020</xref>) or cKit-enriched cells (<xref ref-type="bibr" rid="bib51">Kain et al., 2023</xref>) primarily composed of HSPCs, provided further evidence that primary transplant of trained HSPCs can improve host immunity in subsequent challenges. In studies using the related bacterium <italic>M. avium</italic> as the training agent, we found that similar host protection could persist for 1 year post-primary transplant (<xref ref-type="bibr" rid="bib51">Kain et al., 2023</xref>). Importantly, studies have utilized both mycobacteria and LPS as training agents, suggesting diverse molecular avenues for training (<xref ref-type="bibr" rid="bib30">de Laval et al., 2020</xref>; <xref ref-type="bibr" rid="bib57">Kaufmann et al., 2022</xref>). Trained immunity-mediated host protection was also replicated in the setting of <italic>Rag1</italic>-deficient mice, indicating independence from the adaptive immune system (<xref ref-type="bibr" rid="bib90">Quintin et al., 2012</xref>). We showed that <italic>M. avium</italic> training could confer cross-protective immunity against an antigenically distinct H1N1 influenza challenge, reinforcing the concept that trained immunity protection is not attributable to an adaptive immune response (<xref ref-type="bibr" rid="bib51">Kain et al., 2023</xref>). Multiple studies support this finding (<xref ref-type="bibr" rid="bib57">Kaufmann et al., 2022</xref>; <xref ref-type="bibr" rid="bib25">Ciarlo et al., 2020</xref>; <xref ref-type="bibr" rid="bib59">Khan et al., 2025</xref>).</p></sec><sec id="s2-2"><title>Secondary transplantation to enhance stringency of HSC memory studies</title><p>Serial transplantation is the most stringent functional test of HSC memory capacity, as it requires stem cells to self-renew and generate trilineage hematopoiesis across two or more rounds of transplantation. Serial transplantation of BCG-trained whole bone marrow over a 42-week time period conferred innate immune memory, while a maladaptive memory phenotype induced by <italic>M. tb</italic> likewise was transferred in this transplant model (<xref ref-type="bibr" rid="bib58">Khan et al., 2020</xref>). Secondary transplantation of LPS-stimulated LSK cells 12 weeks apart showed that trained HSCs mediated decreased bacterial burden and increased survival in secondary recipients that had been challenged with lethal doses of <italic>P. aeruginosa</italic> (<xref ref-type="bibr" rid="bib30">de Laval et al., 2020</xref>). These secondary transplant experiments, because they require two rounds of flow cytometric purification of HSPCs, significantly reduce the chance that trained immunity phenotypes are due to transmission of the original pathogen to recipient animals or due to transfer of long-lived adaptive immune cells. Altogether, these studies provide strong evidence that reprogramming of HSPCs results in robust and durable innate immune memory in murine models. However, more direct evidence of HSC involvement in trained immunity is needed, as very few studies to date have utilized direct transplant of purified HSCs, and LSK populations used for multiple studies include numerous progenitors other than HSCs (<xref ref-type="bibr" rid="bib30">de Laval et al., 2020</xref>).</p></sec></sec><sec id="s3"><title>The role of short-term HSCs (ST-HSCs) and multipotent progenitors (MPPs) in innate immune memory conservation</title><p>Transplant models typically involve pre-conditioning regimens such as irradiation or chemotherapy to enable engraftment of transplanted cells (<xref ref-type="bibr" rid="bib42">Hasan et al., 2024</xref>). These harsh regimens induce systemic inflammation, immune cell activation, and disruption of the bone marrow niche, thereby introducing confounding variables to studies (<xref ref-type="bibr" rid="bib73">Mitroulis et al., 2018</xref>). Transplant models also reduce the capacity to study contributions by MPPs or other progenitors which may be long-lived in native hematopoiesis but not after transplant, as mentioned above. While transplant models remain invaluable for addressing questions of cellular origin and lineage tracing, non-transplant approaches provide complementary insights by focusing on the intrinsic properties of HSPCs within a physiologically intact niche, offering a reproducible framework for studying trained immunity (<xref ref-type="bibr" rid="bib80">Netea et al., 2020</xref>; <xref ref-type="bibr" rid="bib10">Bloom et al., 2023</xref>).</p><p>Compared to LT-HSCs, ST-HSCs, and MPPs are thought to have a more limited lifespan of less than 6 months and typically contribute more transiently to hematopoiesis, rapidly cycling to replenish downstream progenitor populations (<xref ref-type="bibr" rid="bib99">Sun et al., 2014</xref>; <xref ref-type="bibr" rid="bib13">Busch and Rodewald, 2016</xref>; <xref ref-type="bibr" rid="bib87">Pei et al., 2017</xref>; <xref ref-type="bibr" rid="bib21">Cheng et al., 2020</xref>; <xref ref-type="bibr" rid="bib33">Ema et al., 2014</xref>). ST-HSCs and MPPs retain multipotency, a high proliferation potential compared to LT-HSCs, and a strong commitment to lineage differentiation, serving as critical intermediates that amplify cell numbers and ensure robust generation of lineage-restricted progenitors, thereby supporting the rapid production of fully differentiated immune cells (<xref ref-type="bibr" rid="bib46">Höfer and Rodewald, 2018</xref>). MPP2, MPP3, and MPP4 exhibit distinct lineage biases, with MPP2 favoring megakaryocytic/erythroid differentiation, MPP3 displaying a myeloid bias, and MPP4 predominantly contributing to lymphoid lineages (see <xref ref-type="box" rid="box1">Box 1</xref>; <xref ref-type="bibr" rid="bib88">Pietras et al., 2015</xref>; <xref ref-type="bibr" rid="bib54">Kang et al., 2023</xref>). Unlike LT-HSCs, ST-HSCs, and MPPs do not sustain hematopoiesis over extended periods of time following transplantation, making it difficult to study the contribution of these cells in transplant models.</p><p>Several non-transplant studies reveal a possible role for ST-HSCs and MPPs in central trained immunity. Conserved transcriptional and epigenetic alterations, including upregulation of C/EBPβ, increased chromatin accessibility at innate immunity genes marked by H3K4me3 (<xref ref-type="bibr" rid="bib30">de Laval et al., 2020</xref>), and metabolic reprogramming toward enhanced glycolysis <xref ref-type="bibr" rid="bib71">Mills et al., 2024</xref> have been shown to occur in LT-HSCs that confer trained immunity in transplant models. These same transcriptional and epigenetic alterations are conserved in the ST-HSC and MPP compartments of recipients of trained LT-HSCs, suggesting that these cells may act as potent producers of innate immune memory effector cells. Following the induction of innate immune training with BCG vaccination or the fungal cell wall component β-glucan, ST-HSCs and MPPs exhibited enhanced expression of gene sets involved in DNA replication and cell division, as well as upregulation of several myeloid-lineage transcription factors at the expense of lymphoid-lineage TFs, indicating a skewing toward myelopoiesis (<xref ref-type="bibr" rid="bib56">Kaufmann et al., 2018</xref>; <xref ref-type="bibr" rid="bib73">Mitroulis et al., 2018</xref>). However, whether this expansion is autonomously driven by ST-HSCs and MPPs or is a result of upstream reprogramming of LT-HSCs remains an open question. Profiling the clonal dynamics of individual HSPC subsets after training stimuli may provide insight into which compartments are being transiently activated versus durably ‘trained’. Lineage tracing approaches, including inducible genetic barcoding systems or tamoxifen-inducible Cre drivers (<xref ref-type="bibr" rid="bib66">Li et al., 2023</xref>), offer a promising avenue to directly test the origins of expanded progenitor subsets in response to innate immune training.</p><p>ST-HSC and MPP compartments have high proliferative capacity and fast differentiation dynamics compared to LT-HSCs, potentially making them better suited to respond to immediate immunological demands. Not only do they exhibit more pronounced transcriptional responses upon inflammatory stimulation than LT-HSCs, but they also have greater expansion capacity. It has been demonstrated that ST-HSCs and MPPs, particularly MPP3s, increase in number following BCG- (<xref ref-type="bibr" rid="bib56">Kaufmann et al., 2018</xref>)<bold>,</bold> β-glucan- (<xref ref-type="bibr" rid="bib73">Mitroulis et al., 2018</xref>), and heme-induced (<xref ref-type="bibr" rid="bib49">Jentho et al., 2021</xref>) trained immunity, reflecting an expansion of the myeloid-biased progenitor pool. This expansion, coupled with conserved transcriptional changes, ensures a sustained supply of functionally reprogrammed myeloid cells that have been shown to execute robust antimicrobial activity against secondary challenge with <italic>M. tb</italic> (<xref ref-type="bibr" rid="bib56">Kaufmann et al., 2018</xref>) or display enhanced metabolic activity in response to LPS (<xref ref-type="bibr" rid="bib73">Mitroulis et al., 2018</xref>).</p><p>A key outstanding question in the field is whether LT-HSCs act as memory reservoirs that transmit trained states downstream to shorter-lived progenitors, or if ST-HSCs and MPPs are directly reprogrammed by inflammatory signals without input from LT-HSCs. In our work, we found that transplantation of sorted LT-HSCs alone was not sufficient to confer <italic>in vivo</italic> protection in an <italic>M. avium</italic> model of trained immunity (<xref ref-type="bibr" rid="bib51">Kain et al., 2023</xref>), suggesting that ST-HSCs and MPPs rather than LT-HSCs are responsible for innate immune memory conservation. Nevertheless, further studies are required for confirmation. In addition, the degree to which each cell compartment contributes to innate memory conservation may depend on the nature, duration, and intensity of the training stimulus.</p><p>An indirect test of the functional capacities of ST-HSC- and MPP-derived innate effector cells is to derive monocytes and macrophages from whole bone marrow preparations. Through a 7-day derivation period, whole bone marrow is cultured with granulocyte–macrophage colony-stimulating factor to generate bone-marrow-derived macrophages (BMDMs). Given that ST-HSCs and MPPs are more abundant and produce more BMDMs in such culture conditions compared to LT-HSCs, BMDM cultures provide a useful way to assess how ST-HSCs and MPPs contribute to trained immunity. It has been shown that BMDMs cultured from whole bone marrow of BCG-vaccinated mice are epigenetically imprinted to initiate a more protective response against <italic>M. tb</italic> challenge (<xref ref-type="bibr" rid="bib56">Kaufmann et al., 2018</xref>). The initial <italic>in vivo</italic> training is dependent on IFN-γ, as epigenetic reprogramming of hematopoietic progenitors in BCG-induced trained immunity models does not occur when the IFN-γ receptor is ablated (<xref ref-type="bibr" rid="bib73">Mitroulis et al., 2018</xref>; <xref ref-type="bibr" rid="bib56">Kaufmann et al., 2018</xref>). Several studies have indicated that IFN-γ is required in both establishment of trained immunity and T-cell activated bacterial control (<xref ref-type="bibr" rid="bib37">Flynn et al., 1993</xref>; <xref ref-type="bibr" rid="bib2">Akter et al., 2022</xref>).</p><p>In contrast, maladaptive induction of innate immune memory with <italic>M. tb</italic> has been shown to impede myelopoiesis via a type I IFN-dependent process (<xref ref-type="bibr" rid="bib58">Khan et al., 2020</xref>). Similarly, a high-fat, high-calorie Western diet (<xref ref-type="bibr" rid="bib23">Christ et al., 2018</xref>) reprograms ST-HSCs and MPPs via IL-1β, resulting in reduced MPP abundance and expanded lymphoid-biased MPP4 populations. These alterations result in impaired host immunity with chronic low-grade inflammation (<xref ref-type="bibr" rid="bib23">Christ et al., 2018</xref>) and a weakened ability to control infection (<xref ref-type="bibr" rid="bib58">Khan et al., 2020</xref>).</p><p>Collectively, these findings using non-transplant models highlight that ST-HSCs and MPPs may play a significant role in innate immune memory conservation and amplification.</p><sec id="s3-1"><title>Innate immune memory conservation in granulocyte–monocyte progenitors</title><p>While the focus of central trained immunity research has been on HSCs and MPPs, strong evidence supports a downstream role of granulocyte–monocyte progenitors (GMPs) in central trained immunity. As mentioned above, central trained immunity can lead to a heterogeneity of responders and non-responders within the host (<xref ref-type="bibr" rid="bib105">Verma et al., 2017</xref>; <xref ref-type="bibr" rid="bib51">Kain et al., 2023</xref>), and cellular expansion can be limited to specific subsets of progenitors including MPP3s and GMPs (<xref ref-type="bibr" rid="bib56">Kaufmann et al., 2018</xref>; <xref ref-type="bibr" rid="bib52">Kalafati et al., 2020</xref>; <xref ref-type="bibr" rid="bib22">Cheong et al., 2023</xref>; <xref ref-type="bibr" rid="bib23">Christ et al., 2018</xref>; <xref ref-type="bibr" rid="bib51">Kain et al., 2023</xref>; <xref ref-type="bibr" rid="bib6">Arts et al., 2018</xref>).</p><p>As many studies highlight, significant expansion of GMPs occurs in response to training stimulants including β-glucan (<xref ref-type="bibr" rid="bib52">Kalafati et al., 2020</xref>; <xref ref-type="bibr" rid="bib73">Mitroulis et al., 2018</xref>), LPS (<xref ref-type="bibr" rid="bib30">de Laval et al., 2020</xref>)<bold>,</bold> <italic>M. avium</italic> (<xref ref-type="bibr" rid="bib51">Kain et al., 2023</xref>)<bold>,</bold> <italic>M.</italic> tb (<xref ref-type="bibr" rid="bib58">Khan et al., 2020</xref>), polymicrobial sepsis (<xref ref-type="bibr" rid="bib11">Bomans et al., 2018</xref>), and in autoimmune disease models (<xref ref-type="bibr" rid="bib71">Mills et al., 2024</xref>). Transcriptional and epigenetic studies of GMPs have found a markedly pro-inflammatory signature in GMPs recovered from patients with long COVID-19 infection compared to healthy controls (<xref ref-type="bibr" rid="bib22">Cheong et al., 2023</xref>). Additionally, β-glucan-trained GMPs, which were able to prevent melanoma growth, acquired epigenetic modifications that led to increased chromatin accessibility at genes related to neutrophil immunity, including ROS-producing factors <italic>Ncf1</italic> and <italic>Ncf2</italic> and type I interferon-related factors <italic>Ifnar1</italic>, <italic>Irf1</italic>, and <italic>Ifitm1-3</italic> (<xref ref-type="bibr" rid="bib52">Kalafati et al., 2020</xref>). A study in patients who had recovered from SARS-CoV-2 infection similarly reported a strong type I interferon signature in GMPs both at the single-cell transcription level and chromatin accessibility level (<xref ref-type="bibr" rid="bib22">Cheong et al., 2023</xref>). Indeed, both type I and type II interferons are known to promote HSC division and have been shown to be sufficient to induce central trained immunity by reprogramming HSPCs to result in increased killing capacity of BMDMs and long-lasting metabolic rewiring (<xref ref-type="bibr" rid="bib51">Kain et al., 2023</xref>; <xref ref-type="bibr" rid="bib8">Baldridge et al., 2010</xref>; <xref ref-type="bibr" rid="bib34">Essers et al., 2009</xref>). Notably, GMPs are known to mount a strong response to interferons and, in one study, exhibited a higher level of IRF1 motif enrichment relative to HSCs and MPPs (<xref ref-type="bibr" rid="bib22">Cheong et al., 2023</xref>), highlighting a potential strong contribution of GMPs toward the generation of central trained immunity. However, considering their short life span, it is unlikely that GMPs alone harbor the capacity to maintain long-term central trained immunity.</p></sec></sec><sec id="s4"><title>Epigenetic mechanisms underlying central trained immunity</title><p>Mechanistically, inflammation has been shown to correlate with chromatin modifications in HSPCs that are passed on to downstream cells to amplify subsequent responses to inflammatory challenges (<xref ref-type="bibr" rid="bib80">Netea et al., 2020</xref>; <xref ref-type="bibr" rid="bib27">Cirovic et al., 2020</xref>). Both generation and maintenance of innate immune memory are associated with chromatin modifications such as methylation, lactylation, and acetylation of histones that alter chromatin accessibility and poise specific DNA loci for faster, higher transcriptional induction (<xref ref-type="bibr" rid="bib80">Netea et al., 2020</xref>; <xref ref-type="bibr" rid="bib82">Ochando et al., 2023</xref>, <xref ref-type="bibr" rid="bib119">Ziogas et al., 2025</xref>). Many next-generation sequencing techniques, such as low-input chromatin immunoprecipitation sequencing (ChIP-seq), assay for transposase accessible chromatin (ATAC-seq), cleavage under targets and release using nuclease (CUT&amp;RUN-seq), and cleavage under targets and tagmentation (CUT&amp;TAG-seq), and single-cell sequencing techniques, have permitted researchers to determine the chromatin landscape in these HSPC subpopulations (<xref ref-type="bibr" rid="bib82">Ochando et al., 2023</xref>; <xref ref-type="fig" rid="fig3">Figure 3</xref>).</p><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Methods for analysis of DNA epigenetic modifications.</title><p>(<bold>A</bold>) ATAC-seq (Assay for Transposase-Accessible Chromatin with sequencing). This method determines chromatin accessibility by measuring open chromatin regions with Tn5 transposase, which inserts sequencing adapters into open chromatin regions. These regions are enriched in the sequencing results and correspond to larger sequencing peaks, reflecting where in the genome more transcriptional activity is occurring (<xref ref-type="bibr" rid="bib56">Kaufmann et al., 2018</xref>; <xref ref-type="bibr" rid="bib27">Cirovic et al., 2020</xref>; <xref ref-type="bibr" rid="bib71">Mills et al., 2024</xref>; <xref ref-type="bibr" rid="bib22">Cheong et al., 2023</xref>; <xref ref-type="bibr" rid="bib23">Christ et al., 2018</xref>; <xref ref-type="bibr" rid="bib58">Khan et al., 2020</xref>; <xref ref-type="bibr" rid="bib30">de Laval et al., 2020</xref>; <xref ref-type="bibr" rid="bib57">Kaufmann et al., 2022</xref>; <xref ref-type="bibr" rid="bib50">Johansson et al., 2023</xref>; <xref ref-type="bibr" rid="bib99">Sun et al., 2014</xref>; <xref ref-type="bibr" rid="bib117">Zhang et al., 2017</xref>). (<bold>B</bold>) ChIP-seq (Chromatin Immunoprecipitation with sequencing). This method allows for the determination of protein-binding sites on DNA. Briefly, DNA sequences bound by transcription factors or histone modifications are captured via cross-linking, fragmentation, and immunoprecipitation using an antibody specific to the protein of interest. This method provides data in the form of genome-wide maps illustrating areas of histone modifications or transcription factor binding. (<bold>C</bold>) CUT&amp;RUN-seq (Cleavage Under Targets and Release Using Nuclease sequencing). Much like ChIP-seq, CUT&amp;RUN-seq provides genome-wide maps of protein–DNA interactions, but has a higher resolution and lower background. This method uses an antibody to bind a target protein, such as a transcription factor, followed by recruitment of micrococcal nuclease (A-MNase) fusion protein. This cleaves DNA only near the antibody-bound region, causing release of those fragments for sequencing (<xref ref-type="bibr" rid="bib82">Ochando et al., 2023</xref>; <xref ref-type="bibr" rid="bib64">Le et al., 2023</xref>). (<bold>D</bold>) CUT&amp;TAG-seq (Cleavage Under Targets and TAGmentation sequencing). This method functions similarly to CUT&amp;RUN-seq but provides data with even greater sensitivity and reduced background. After binding by an antibody to the protein of interest, a fusion of protein A to Tn5 transposase directly cuts and inserts sequencing adapters into the DNA at the DNA–protein-binding sites. (<bold>E</bold>) DNA methylation. Genomic DNA is digested with methylation-sensitive restriction enzymes (MSREs), cleaving unmethylated DNA while leaving methylated DNA intact. Digested DNA is then analyzed by reverse transcription-polymerase chain reaction (RT-PCR) with primers that flank the region of interest. Only methylated DNA is amplified, allowing for methylation to be determined by comparing the copies per reaction (Ct) between MSRE-treated and control samples (<xref ref-type="bibr" rid="bib105">Verma et al., 2017</xref>; <xref ref-type="bibr" rid="bib73">Mitroulis et al., 2018</xref>; <xref ref-type="bibr" rid="bib51">Kain et al., 2023</xref>; <xref ref-type="bibr" rid="bib100">Sun et al., 2024</xref>; <xref ref-type="bibr" rid="bib47">Hormaechea-Agulla et al., 2021</xref>; <xref ref-type="bibr" rid="bib50">Johansson et al., 2023</xref>).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-106610-fig3-v1.tif"/></fig><p>In mice, studies have shown that activating histone modifications like H3K4me3 and H3K27ac are enriched at genes associated with innate immune memory such as the metabolic regulator mTOR (<xref ref-type="bibr" rid="bib5">Arts et al., 2016</xref>; <xref ref-type="bibr" rid="bib32">Domínguez-Andrés et al., 2019</xref>) and pro-inflammatory cytokines IL-6 and TNF-α (<xref ref-type="bibr" rid="bib5">Arts et al., 2016</xref>; <xref ref-type="bibr" rid="bib94">Saeed et al., 2014</xref>). Further, sorted HSPCs (LSK+, Flt3-) have been observed to gain H3K4 mono- and tri-methylation and increased chromatin accessibility in response to LPS stimulation at genes involved in inflammatory biological processes, including innate immune response, myeloid differentiation, and anti-bacterial responses (<xref ref-type="bibr" rid="bib30">de Laval et al., 2020</xref>). Notably, upon secondary stimulation, these LPS-trained HSPCs demonstrate a heightened excitability and a significant gain of activating histone marks H3K4me1, H3K27ac, and an overall increase in chromatin accessibility at loci associated with stem cell activation (<xref ref-type="bibr" rid="bib30">de Laval et al., 2020</xref>). Using CUT&amp;RUN sequencing, activating H3K27ac marks in SLAM-HSCs (Lin-, cKit+, CD48−, CD150+) have been shown to correlate with enhanced cytokine production such as the chemokine CCL5, upon <italic>M. avium</italic> infection (<xref ref-type="bibr" rid="bib64">Le et al., 2023</xref>). Finally, metabolic processes, like oxidative phosphorylation (<xref ref-type="bibr" rid="bib100">Sun et al., 2024</xref>) and glycolysis (<xref ref-type="bibr" rid="bib71">Mills et al., 2024</xref>), coincide with immune training (<xref ref-type="bibr" rid="bib1">Abhimanyu et al., 2024</xref>). These findings highlight the potential for HSCs to gain common activating histone modifications upon inflammatory stimulation, contributing to trained immunity phenotypes. However, more studies into the histone landscape of HSPCs upon inflammation are needed, as a wide range of different modifications and their mechanistic contribution to the memory phenotype remain unexplored.</p><p>Single-cell sequencing studies in human HSPCs corroborate that long-term transcriptional and epigenetic reprogramming in HSPCs can be retained in myeloid-lineage cells. For example, BCG-trained CD34<sup>+</sup> human HSPCs retained transcriptional bias and chromatin accessibility toward neutrophil activation (<xref ref-type="bibr" rid="bib27">Cirovic et al., 2020</xref>; <xref ref-type="bibr" rid="bib100">Sun et al., 2024</xref>). While this reprogramming did not alter cell numbers or baseline function, these BCG-trained bone marrow-derived mononuclear cells showed heightened cytokine responses after being challenged with <italic>Candida albicans</italic>. Furthermore, a recent study showed that inflammation-induced reprogramming of HSCs and GMPs could be detected in human patients 6 months after recovery from SARS-CoV-2 infection, resulting in a persistent myeloid differentiation bias and hyperinflammatory state (<xref ref-type="bibr" rid="bib22">Cheong et al., 2023</xref>). These long-lasting changes included durable alterations in chromatin accessibility at genes such as <italic>CXCR4</italic>, <italic>CCL5</italic>, and <italic>GBP5</italic> that remained open for almost a year post-SARS-CoV-2 infection.</p><p>In addition to chromatin accessibility and histone modifications, DNA methylation has also been found to be altered in HSPCs after infection. DNA methyltransferase DNMT3A is the main cellular enzyme responsible for de novo methylation of cytosine to generate 5-methylcytosine, a mark that typically represses transcription. Interestingly, we and others showed that loci encoding transcription factors such as <italic>Batf2</italic>, <italic>Fos</italic>, and <italic>Jun</italic>, important in myeloid differentiation (<xref ref-type="bibr" rid="bib69">Matatall et al., 2016</xref>; <xref ref-type="bibr" rid="bib67">Liebermann et al., 1998</xref>; <xref ref-type="bibr" rid="bib102">Taylor et al., 2024</xref>) were hypermethylated and transcriptionally repressed in <italic>Dnmt3a</italic>-mutant HSCs after infection (<xref ref-type="bibr" rid="bib47">Hormaechea-Agulla et al., 2021</xref>). On the other hand, DNA methylation silences critical immune response genes in contexts like LPS or <italic>M. tb</italic>-induced immune tolerance (<xref ref-type="bibr" rid="bib1">Abhimanyu et al., 2024</xref>). These findings imply that DNA methylation regulates gene transcription in the setting of infection. Despite these discoveries, the role of DNA methylation in central trained immunity remains largely unexplored.</p><p>A common set of transcription factor motifs has emerged across epigenetic studies of trained immunity. As noted above, we found that BATF2 was differentially regulated in response to infection in Dnmt3a-KO mice. Further, the loss of <italic>Batf2</italic> (<xref ref-type="bibr" rid="bib64">Le et al., 2023</xref>) disrupted downstream macrophage responses to pathogen challenge, highlighting its role in initiation of immune responses (<xref ref-type="bibr" rid="bib64">Le et al., 2023</xref>). Likewise, the transcription factor CEBPβ, which is known to open chromatin and promote transcription of other TFs (AP1, IRF, and ATF) as well as innate immune response and myeloid differentiation genes such as <italic>Ifnar2</italic>, <italic>Mx2</italic>, and <italic>Itih5</italic> (<xref ref-type="bibr" rid="bib69">Matatall et al., 2016</xref>), has been shown to play a critical role in LPS-induced epigenetic reprogramming and central trained memory (<xref ref-type="bibr" rid="bib30">de Laval et al., 2020</xref>). In patients with long-SARS-CoV-2, similar transcription factor programs were altered in HSPCs and monocytes, with heightened activity of TFs like JUN, NFKB1, and NFKB2, and interferon regulatory family TFs (<xref ref-type="bibr" rid="bib22">Cheong et al., 2023</xref>). In embryonic epidermal stem cells during skin injury and repair, transcription factors including FOS and JUN act as a switch triggered by the initial training stimulus to direct stem cells’ response to different pathogens (<xref ref-type="bibr" rid="bib113">Yang et al., 2023</xref>; <xref ref-type="bibr" rid="bib72">Missinato et al., 2023</xref>). Altogether, these studies highlight the activation of specific TFs as a critical step in central trained immunity. This raises the possibility that transcription factors act as pioneer factors which open chromatin to enable the acquisition of DNA methylation and histone modifications. Whether chromatin marks or transcription factors are the key initiating event for central trained immunity remains an active area of research in the field (<xref ref-type="bibr" rid="bib80">Netea et al., 2020</xref>; <xref ref-type="bibr" rid="bib82">Ochando et al., 2023</xref>).</p><p>Altogether, histone modifications and chromatin openness at key transcription factor binding motifs have been shown to be conserved in HSCs and downstream effector myeloid cells after immune training, suggesting that conserved chromatin accessibility changes may provide the mechanism for enhanced innate immune responses in central trained immunity. However, the mechanisms by which such marks are passed down through ontogeny remain undefined. Are transcription factors stable enough to remain associated with chromatin through cell division and thereby facilitate histone modifications? Or are these histone modifications conserved through cell divisions that occur during differentiation? These challenging questions will serve as guideposts for future research.</p></sec><sec id="s5"><title>Heterogeneity of HSPC responses</title><p>While a variety of stimulants produce trained immunity phenotypes, a common set of inflammatory cytokines plays key mechanistic roles downstream of these stimulants. Cytokines including IL-6 (<xref ref-type="bibr" rid="bib22">Cheong et al., 2023</xref>), IFNs (<xref ref-type="bibr" rid="bib56">Kaufmann et al., 2018</xref>; <xref ref-type="bibr" rid="bib58">Khan et al., 2020</xref>), and IL-1 (<xref ref-type="bibr" rid="bib75">Moorlag et al., 2020</xref>) are commonly reported inducers of innate memory in models of trained immunity. These cytokines, particularly IL-6 and IL-1, can be produced both by HSPCs themselves (<xref ref-type="bibr" rid="bib41">Granick et al., 2012</xref>), their progeny, as well as immune and niche cells in the bone marrow microenvironment which therefore contribute significantly to trained immunity induction (<xref ref-type="bibr" rid="bib74">Mitroulis et al., 2020</xref>). We demonstrated that IFNγ is essential for trained immunity, as the loss of the IFNγ receptor resulted in the abrogation of trained immunity protection (<xref ref-type="bibr" rid="bib56">Kaufmann et al., 2018</xref>). IL-1 and type I IFN are crucial for β-glucan-mediated trained immunity (<xref ref-type="bibr" rid="bib52">Kalafati et al., 2020</xref>; <xref ref-type="bibr" rid="bib73">Mitroulis et al., 2018</xref>; <xref ref-type="bibr" rid="bib75">Moorlag et al., 2020</xref>; <xref ref-type="bibr" rid="bib40">Gow et al., 2007</xref>)<bold>,</bold> leading to proliferation and differential skewing of hematopoietic progenitor cells. Specifically, GMPs, Gr1<sup>+</sup>CD11b<sup>+</sup> cells, and myeloid cells proliferate and serve in a protective role, such as in neutrophil-mediated anti-cancer responses (<xref ref-type="bibr" rid="bib52">Kalafati et al., 2020</xref>; <xref ref-type="bibr" rid="bib39">Geller et al., 2022</xref>) and macrophage-mediated responses to control <italic>M. tb</italic> (<xref ref-type="bibr" rid="bib75">Moorlag et al., 2020</xref>). Moorlag et al. demonstrated that reprogramming of HSPCs relied on IL-1, as inhibition of IL-1 signaling impaired the effects of β-glucan-mediated trained immunity (<xref ref-type="bibr" rid="bib75">Moorlag et al., 2020</xref>).</p><p>These studies highlight the necessity of inflammatory cytokines for the generation of central trained immunity. Notably, inflammatory cytokines like IL-6 are elevated in aging and promote myeloid-biased differentiation and hyperinflammatory innate immune cells, a concept known as inflammaging (<xref ref-type="bibr" rid="bib24">Chung et al., 2006</xref>). Considering the similarities between inflammaging and trained immunity, the question of whether cytokines alone can confer trained immunity is a field of active investigation. We showed that a single dose of recombinant IFNγ reprograms HSPCs leading to higher metabolism and more robust and efficient immune responses in the downstream macrophages (<xref ref-type="bibr" rid="bib51">Kain et al., 2023</xref>). This phenotype persisted even after HSPC transplant. The question remaining is whether a strong enough cytokine signal, or combination of cytokines, is indeed sufficient to generate central trained immunity, or whether stimuli recognition itself has shaping potential for the epigenetic reprogramming and downstream immune response. Upcoming studies are geared to clarify whether ‘clean’ training stimulants, such as pure cytokine cocktails, are sufficient to promote central training and host immunity.</p><p>Notably, studies indicate that HSPCs do not all respond to inflammatory cytokine stimulation alike, opening the possibility that specific subpopulations get differentially programmed with every inflammatory insult. HSCs express receptors for inflammatory cytokines and pathogen-associated molecular patterns that shape HSC cellular and transcriptional outputs. Both human and murine HSPCs express many pathogen recognition receptors such as TLR-1, TLR2, TLR3, TLR4, TLR6, TLR7, TLR8, NOD, RigI-like receptors, and STING/GAS that can directly interact with stimuli, activate downstream signaling pathways, and promote HSC loss of quiescence (<xref ref-type="bibr" rid="bib60">King and Goodell, 2011</xref>; <xref ref-type="bibr" rid="bib8">Baldridge et al., 2010</xref>). For instance, HSCs process LPS through interactions with TLR4, recruiting C/EBPβ to result in a transient increase of LT-HSCs, MPP2, MPP3, and GMP numbers and stable changes in chromatin accessibility of Flt3<sup>−</sup>LSK cells (<xref ref-type="bibr" rid="bib30">de Laval et al., 2020</xref>). Single-cell studies indicate that HSPCs differentially process inflammatory signals to initiate the reprogramming that produces and maintains central trained immunity, leading to heterogeneity in responses (<xref ref-type="bibr" rid="bib51">Kain et al., 2023</xref>).</p><p>Despite the recognition that HSPCs are highly heterogeneous, it remains unknown if all HSPCs have equal capacity for innate immune memory. Initial studies of BCG-vaccinated humans found that not all patients developed trained immune memory (<xref ref-type="bibr" rid="bib105">Verma et al., 2017</xref>). Taking peripheral monocytes from healthy volunteers pre and post BCG vaccination, Verma et al. described varying levels of cytokine production in response to <italic>in vitro</italic> stimulation, thus categorizing subjects into ‘responders’ and ‘non-responders’. BCG responsive changes were attributed to DNA hypomethylation at regions such as <italic>ADCY3</italic>, leading to immune activation. The researchers did not study histone modifications in this study, but others have recently found increased chromatin accessibility in HSPCs of BCG-vaccinated individuals (<xref ref-type="bibr" rid="bib100">Sun et al., 2024</xref>). This variability in response raises questions about the universality of trained immunity as an immunization strategy and highlights that genetic factors or environmental conditions may contribute to trained immunity in yet unknown ways.</p><p>Responder and non-responder variability has also been observed on a cellular level in HSPC single-cell transcriptomic studies in various inflammation models, including BCG vaccination (<xref ref-type="bibr" rid="bib56">Kaufmann et al., 2018</xref>), LPS stimulation (<xref ref-type="bibr" rid="bib30">de Laval et al., 2020</xref>), and <italic>M. avium</italic> infection (<xref ref-type="bibr" rid="bib51">Kain et al., 2023</xref>). In some cases, distinct transcriptional states within HSPCs could be clustered in alignment with fate determination. Specifically, single-cell RNA sequencing on bone marrow HSPCs revealed multiple clusters of MPP3s, with one cluster containing a transcriptional signature indicative of granulocytic bias (<xref ref-type="bibr" rid="bib57">Kaufmann et al., 2022</xref>). Similarly, a single-cell RNA sequencing study of HSPCs in the setting of <italic>M. avium</italic> infection revealed heterogenous transcriptional responses, with a minority of cells driving the significant upregulation of inflammatory genes (<xref ref-type="bibr" rid="bib51">Kain et al., 2023</xref>). Altogether, these single-cell studies indicate that HSPC populations do not respond as a monolith to inflammatory stimuli; rather, there is significant heterogeneity even within cell types to produce appropriate inflammatory responses. Thus, trained immunity phenotypes may be driven by a small subset of total HSPCs. It is tempting to speculate that heterogeneous reprogramming is an adaptive feature, allowing non-responsive HSPCs to continue basal functions or be poised for future training by alternative agents. Alternatively, heterogeneity may be due to spatial variation in infection and inflammatory cytokine density and spatial distribution of the HSPCs in the bone marrow. Spatial transcriptomics methods (<xref ref-type="bibr" rid="bib28">Crosse et al., 2020</xref>) could shed light on whether ‘responder’ cells are clustered relative to hubs of infection or mature responder cells producing cytokines in the bone marrow.</p><p>With the expansion of single-cell sequencing, a growing body of literature suggests heterogeneity even within the canonically defined HSC compartment (LSK, CD150-negative, CD48-positive) at baseline and upon inflammatory activation. For instance, myeloid-biased CD41-positive HSCs (<xref ref-type="bibr" rid="bib38">Gekas and Graf, 2013</xref>) are a potential driver of central trained immunity (<xref ref-type="bibr" rid="bib73">Mitroulis et al., 2018</xref>; <xref ref-type="bibr" rid="bib51">Kain et al., 2023</xref>; <xref ref-type="bibr" rid="bib30">de Laval et al., 2020</xref>). We recently described an infection-activated HSC subset (IA-HSC) stimulated by <italic>M. avium</italic> that expresses both LSK and activation markers, such as CD81, CD24a, and CD9 (<xref ref-type="bibr" rid="bib51">Kain et al., 2023</xref>). Notably, the IA-HSCs can be sorted and transplanted in murine models, thus providing the potential to investigate whether these cells are the source of trained immunity. Similar subsets of ‘inflammatory memory’ HSCs have been identified in human studies (<xref ref-type="bibr" rid="bib116">Zeng et al., 2023</xref>). Future studies aim at parsing out how the heterogeneity in HSCs relates to trained immunity phenotypes, while deeper epigenetic sequencing methodologies (<xref ref-type="fig" rid="fig3">Figure 3</xref>) will enable further definition of HSC subpopulations both in health and disease in humans (<xref ref-type="bibr" rid="bib116">Zeng et al., 2023</xref>).</p><p>Preferential expansion of a specific HSPC subset is reminiscent of clonal hematopoiesis of indeterminate potential (CHIP), a preleukemic condition in which the bone marrow of older individuals harbors an expanding population of cell clones with somatic mutations, often in cancer-driver genes (<xref ref-type="bibr" rid="bib48">Jaiswal and Ebert, 2019</xref>). Like trained immunity, CHIP clones can respond to environmental stressors like inflammation and significantly expand their progeny, ultimately gaining a cellular advantage in the bone marrow and peripheral blood (<xref ref-type="bibr" rid="bib15">Cao et al., 2024</xref>; <xref ref-type="bibr" rid="bib36">Florez et al., 2022</xref>; <xref ref-type="bibr" rid="bib7">Avagyan and Zon, 2023</xref>). Inflammation-mediated expansion, epigenetic changes, and cancer predisposition are fundamental themes shared between the fields of central trained immunity and CHIP (<xref ref-type="bibr" rid="bib19">Chavakis et al., 2022</xref>). As such, it is worthwhile to consider whether responder cells poised for trained immunity exist within hosts in the same way that rare somatic mutations arise, and whether inflammatory training may lead to their expansion and selective advantage like in CHIP clones. Indeed, if innate immune memory is actually achieved by selection and expansion of preexisting populations, perhaps central trained immunity is really a manifestation of clonal selection rather than training and immunological memory.</p></sec><sec id="s6"><title>Summary and future directions</title><p>In sum, recent studies provide strong evidence that HSPCs can cell autonomously sustain trained immunity phenotypes in both mice and humans, supporting long-term production of innate memory effector cells with enhanced immune function. The mechanisms by which HSPCs support central trained immunity are fascinating. Here, we have described two major and non-mutually exclusive mechanisms: (1) inflammatory stimuli select and alter lineage fate determination of HSPC progeny, reshaping immune cell populations; (2) reprogramming of HSPCs generates downstream progeny that are transcriptionally and metabolically poised for enhanced immune function. Indeed, both mechanisms seem to occur in parallel. While the field of central trained immunity continues to expand, many unknowns remain. The following questions remain critical priorities to translate central trained immunity for therapeutic benefit.</p><p>First, epigenetic mechanisms by which HSPCs maintain central trained immunity remain poorly understood. Transplant studies indicate that HSPCs sustain changes that last for months or years and can be passed to progeny cells, implying an epigenetic change. While histone modifications and DNA methylation are considered the mediators of reprogramming signatures, the causal relationship between chromatin marks and trained immunity has not been defined through loss of function studies. Likewise, the association of specific epigenetic marks with defined training results is still pending. Most studies have focused on H3K4me3 and H3K27ac, but these are typically transient marks; a number of other marks may be better candidates for memory functions. Loss and gain of function studies will indisputably demonstrate a role for a particular chromatin modification, gene locus, or transcription factor in trained immunity, which can ultimately also be therapeutically targeted for enhancement or clearance.</p><p>Second, alternative mechanisms for HSC memory induction such as sustained changes in mitochondria need to be considered (<xref ref-type="bibr" rid="bib12">Bonora et al., 2024</xref>; <xref ref-type="bibr" rid="bib45">Hinge et al., 2020</xref>). Just as epigenetic reprogramming is critical for trained immunity, it is well documented that metabolic rewiring, particularly at the mitochondrial level, is critical for innate immune memory (<xref ref-type="bibr" rid="bib80">Netea et al., 2020</xref>; <xref ref-type="bibr" rid="bib5">Arts et al., 2016</xref>; <xref ref-type="bibr" rid="bib1">Abhimanyu et al., 2024</xref>). Notably, the methyl groups and acetyl-CoA that serve as key substrates for epigenetic modifications are products of mitochondrial metabolism (<xref ref-type="bibr" rid="bib80">Netea et al., 2020</xref>; <xref ref-type="bibr" rid="bib35">Ferreira et al., 2024</xref>; <xref ref-type="bibr" rid="bib92">Riksen and Netea, 2021</xref>; <xref ref-type="bibr" rid="bib111">Wu et al., 2023</xref>). Considering that alterations in critical metabolic pathways such as oxidative phosphorylation in HSPCs are consistently observed in trained immunity models (<xref ref-type="bibr" rid="bib71">Mills et al., 2024</xref>; <xref ref-type="bibr" rid="bib100">Sun et al., 2024</xref>; <xref ref-type="bibr" rid="bib1">Abhimanyu et al., 2024</xref>), metabolic rewiring may in fact be the driver of epigenetic alterations.</p><p>Third, as described throughout this review, hematopoietic cells at different stages of differentiation, from HSCs to lineage-committed progenitors, contribute to central trained immunity. The HSPC subcompartment most critical for trained immunity remains unknown, and the major responders and mediators may be context dependent. Current research relies on transplantation of mixed HSPC populations that are limited by the low number of primitive cells and short lifespan of downstream progeny. It is worth acknowledging that murine transplant studies do not rule out the possibility that trained immunity may be transmitted by non-cell autonomous mechanisms (e.g. alterations of the niche). However, they do provide strong rationale for pursuing further mechanistic studies of cell autonomous central trained immunity, with potential benefits for HSC transplant recipients. In the future, <italic>in vivo</italic> barcoding and mosaic models will enhance these studies. Single-cell and spatial multiomic studies will ultimately address how many reprogrammed HSPCs are necessary to generate functionally relevant degrees of immune protection. Furthermore, these studies will elucidate whether innate memory protection induced by one specific stimulus diminishes trained immunity potential for other stimuli. Finally, detailed studies of changes in the bone marrow niche after inflammatory challenge will shed light on non-cell autonomous mechanisms for central trained immunity.</p><p>Enhanced immunity conferred by innate immune training has exciting translational potential. Providing nonspecific enhanced immunity would be of critical value in the setting of novel pandemics for which antigen-specific vaccines are not yet available. Further, immune training of HSPCs could improve outcomes for recipients of bone marrow transplants, for whom infection remains a leading cause of death. However, wide heterogeneity in HSPC transcriptional responses and epigenetic marks in trained immunity studies, in both murine and human trials, remains a major limiting factor for translation of trained immunity. Studies such as those published by Verma et al. show that current approaches to induce trained immunity may not be successful for everyone, even with a healthy background (<xref ref-type="bibr" rid="bib105">Verma et al., 2017</xref>). Furthermore, the variable memory observed in long-COVID patients indicates that trained immunity responses may be maladaptive for some individuals (<xref ref-type="bibr" rid="bib22">Cheong et al., 2023</xref>). Thus, many more studies to explicate the cellular and molecular basis of trained immunity are needed to actualize these goals.</p><p>In summary, it is an exciting time for research into central trained immunity. Inflammatory training of HSPCs confers long-term enhanced immunity against secondary infectious challenges with measurable changes in prevalence and function of progenitors and innate immune cells. Current studies indicate that immunological training throughout life may shape the evolution of the stem and progenitor cell compartment, yielding manifold layers of immune memory. This phenomenon has been described in human epidemiologic and single-cell functional studies and is reproducible in mouse models, with clear implications for human health. While the crucial role of HSPCs in maintenance of memory function in innate immune cells has been revealed, the field is now poised to address the detailed mechanistic basis for this phenomenon. Future clinical research envisions the development of methodologies to train donor HSPCs prior to transplant, resulting in reduced infectious complications after transplant. Alternatively, elucidation of cellular sources of trained immunity may lead to strategies to select for these cells as an immunologically enhanced donor pool. Finally, elucidating the epigenetic bases for trained immunity may lead to bioengineering approaches that recreate these effects in patients without the need for immune training. Such approaches can be utilized in the clinic to offset immune dysfunction in aging, to enhance tumor immunotherapy, or to curb the dangerous effects of autoimmunity.</p><p><xref ref-type="table" rid="table1">Table 1</xref> describes the different subpopulations of HSPCs that have been shown to conserve trained immunity signatures. Depending on the HSPC population, trained immunity has still been observed at specific selected experimental endpoints spanning from a few weeks to years post-training. Reversal or loss of training signatures has yet to be demonstrated.</p></sec></body><back><sec sec-type="additional-information" id="s7"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Visualization, Writing – original draft</p></fn><fn fn-type="con" id="con2"><p>Visualization, Writing – original draft</p></fn><fn fn-type="con" id="con3"><p>Visualization, Writing – original draft</p></fn><fn fn-type="con" id="con4"><p>Supervision, Funding acquisition, Project administration, Writing – review and editing</p></fn><fn fn-type="con" id="con5"><p>Conceptualization, Supervision, Funding acquisition, Project administration, Writing – review and editing</p></fn></fn-group></sec><ack id="ack"><title>Acknowledgements</title><p>This project was supported by grants from the NIH: T32HL2332 (BTT), F31HL164287 (BTT), R35 HL155672 (KYK), and P01 CA265748 (KYK). This work has also been supported by funds from Banting Research Foundation and CIHR to EK, who also holds the Canada Research Chair Tier 2 in Immunology and Inflammation.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abhimanyu</surname><given-names>A</given-names></name><name><surname>Longlax</surname><given-names>SC</given-names></name><name><surname>Nishiguchi</surname><given-names>T</given-names></name><name><surname>Ladki</surname><given-names>M</given-names></name><name><surname>Sheikh</surname><given-names>D</given-names></name><name><surname>Martinez</surname><given-names>AL</given-names></name><name><surname>Mace</surname><given-names>EM</given-names></name><name><surname>Grimm</surname><given-names>SL</given-names></name><name><surname>Caldwell</surname><given-names>T</given-names></name><name><surname>Portillo Varela</surname><given-names>A</given-names></name><name><surname>Sekhar</surname><given-names>RV</given-names></name><name><surname>Mandalakas</surname><given-names>AM</given-names></name><name><surname>Mlotshwa</surname><given-names>M</given-names></name><name><surname>Ginidza</surname><given-names>S</given-names></name><name><surname>Cirillo</surname><given-names>JD</given-names></name><name><surname>Wallis</surname><given-names>RS</given-names></name><name><surname>Netea</surname><given-names>MG</given-names></name><name><surname>van Crevel</surname><given-names>R</given-names></name><name><surname>Coarfa</surname><given-names>C</given-names></name><name><surname>DiNardo</surname><given-names>AR</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>TCA metabolism regulates DNA hypermethylation in LPS and <italic>Mycobacterium tuberculosis</italic>-induced immune tolerance</article-title><source>PNAS</source><volume>121</volume><elocation-id>e2404841121</elocation-id><pub-id pub-id-type="doi">10.1073/pnas.2404841121</pub-id><pub-id pub-id-type="pmid">39348545</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akter</surname><given-names>S</given-names></name><name><surname>Chauhan</surname><given-names>KS</given-names></name><name><surname>Dunlap</surname><given-names>MD</given-names></name><name><surname>Choreño-Parra</surname><given-names>JA</given-names></name><name><surname>Lu</surname><given-names>L</given-names></name><name><surname>Esaulova</surname><given-names>E</given-names></name><name><surname>Zúñiga</surname><given-names>J</given-names></name><name><surname>Artyomov</surname><given-names>MN</given-names></name><name><surname>Kaushal</surname><given-names>D</given-names></name><name><surname>Khader</surname><given-names>SA</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title><italic>Mycobacterium tuberculosis</italic> infection drives a type I IFN signature in lung lymphocytes</article-title><source>Cell Reports</source><volume>39</volume><elocation-id>110983</elocation-id><pub-id pub-id-type="doi">10.1016/j.celrep.2022.110983</pub-id><pub-id pub-id-type="pmid">35732116</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Amoodi</surname><given-names>AS</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Al-Ghuneim</surname><given-names>A</given-names></name><name><surname>Allehaibi</surname><given-names>H</given-names></name><name><surname>Isaioglou</surname><given-names>I</given-names></name><name><surname>Esau</surname><given-names>LE</given-names></name><name><surname>AbuSamra</surname><given-names>DB</given-names></name><name><surname>Merzaban</surname><given-names>JS</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Refining the migration and engraftment of short-term and long-term HSCs by enhancing homing-specific adhesion mechanisms</article-title><source>Blood Advances</source><volume>6</volume><fpage>4373</fpage><lpage>4391</lpage><pub-id pub-id-type="doi">10.1182/bloodadvances.2022007465</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anjos-Afonso</surname><given-names>F</given-names></name><name><surname>Bonnet</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Human CD34+ hematopoietic stem cell hierarchy: how far are we with its delineation at the most primitive level?</article-title><source>Blood</source><volume>142</volume><fpage>509</fpage><lpage>518</lpage><pub-id pub-id-type="doi">10.1182/blood.2022018071</pub-id><pub-id pub-id-type="pmid">37018661</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arts</surname><given-names>RJW</given-names></name><name><surname>Carvalho</surname><given-names>A</given-names></name><name><surname>La Rocca</surname><given-names>C</given-names></name><name><surname>Palma</surname><given-names>C</given-names></name><name><surname>Rodrigues</surname><given-names>F</given-names></name><name><surname>Silvestre</surname><given-names>R</given-names></name><name><surname>Kleinnijenhuis</surname><given-names>J</given-names></name><name><surname>Lachmandas</surname><given-names>E</given-names></name><name><surname>Gonçalves</surname><given-names>LG</given-names></name><name><surname>Belinha</surname><given-names>A</given-names></name><name><surname>Cunha</surname><given-names>C</given-names></name><name><surname>Oosting</surname><given-names>M</given-names></name><name><surname>Joosten</surname><given-names>LAB</given-names></name><name><surname>Matarese</surname><given-names>G</given-names></name><name><surname>van Crevel</surname><given-names>R</given-names></name><name><surname>Netea</surname><given-names>MG</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Immunometabolic pathways in BCG-induced trained immunity</article-title><source>Cell Reports</source><volume>17</volume><fpage>2562</fpage><lpage>2571</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2016.11.011</pub-id><pub-id pub-id-type="pmid">27926861</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arts</surname><given-names>RJW</given-names></name><name><surname>Moorlag</surname><given-names>S</given-names></name><name><surname>Novakovic</surname><given-names>B</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>SY</given-names></name><name><surname>Oosting</surname><given-names>M</given-names></name><name><surname>Kumar</surname><given-names>V</given-names></name><name><surname>Xavier</surname><given-names>RJ</given-names></name><name><surname>Wijmenga</surname><given-names>C</given-names></name><name><surname>Joosten</surname><given-names>LAB</given-names></name><name><surname>Reusken</surname><given-names>C</given-names></name><name><surname>Benn</surname><given-names>CS</given-names></name><name><surname>Aaby</surname><given-names>P</given-names></name><name><surname>Koopmans</surname><given-names>MP</given-names></name><name><surname>Stunnenberg</surname><given-names>HG</given-names></name><name><surname>van Crevel</surname><given-names>R</given-names></name><name><surname>Netea</surname><given-names>MG</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>BCG Vaccination protects against experimental viral infection in humans through the induction of cytokines associated with trained immunity</article-title><source>Cell Host &amp; Microbe</source><volume>23</volume><fpage>89</fpage><lpage>100</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2017.12.010</pub-id><pub-id pub-id-type="pmid">29324233</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Avagyan</surname><given-names>S</given-names></name><name><surname>Zon</surname><given-names>LI</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Clonal hematopoiesis and inflammation - the perpetual cycle</article-title><source>Trends in Cell Biology</source><volume>33</volume><fpage>695</fpage><lpage>707</lpage><pub-id pub-id-type="doi">10.1016/j.tcb.2022.12.001</pub-id><pub-id pub-id-type="pmid">36593155</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baldridge</surname><given-names>MT</given-names></name><name><surname>King</surname><given-names>KY</given-names></name><name><surname>Boles</surname><given-names>NC</given-names></name><name><surname>Weksberg</surname><given-names>DC</given-names></name><name><surname>Goodell</surname><given-names>MA</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Quiescent haematopoietic stem cells are activated by IFN-gamma in response to chronic infection</article-title><source>Nature</source><volume>465</volume><fpage>793</fpage><lpage>797</lpage><pub-id pub-id-type="doi">10.1038/nature09135</pub-id><pub-id pub-id-type="pmid">20535209</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Belle</surname><given-names>JI</given-names></name><name><surname>Petrov</surname><given-names>JC</given-names></name><name><surname>Langlais</surname><given-names>D</given-names></name><name><surname>Robert</surname><given-names>F</given-names></name><name><surname>Cencic</surname><given-names>R</given-names></name><name><surname>Shen</surname><given-names>S</given-names></name><name><surname>Pelletier</surname><given-names>J</given-names></name><name><surname>Gros</surname><given-names>P</given-names></name><name><surname>Nijnik</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Repression of p53-target gene Bbc3/PUMA by MYSM1 is essential for the survival of hematopoietic multipotent progenitors and contributes to stem cell maintenance</article-title><source>Cell Death and Differentiation</source><volume>23</volume><fpage>759</fpage><lpage>775</lpage><pub-id pub-id-type="doi">10.1038/cdd.2015.140</pub-id><pub-id pub-id-type="pmid">26768662</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bloom</surname><given-names>M</given-names></name><name><surname>Malouf</surname><given-names>C</given-names></name><name><surname>Rodriguez-Fraticelli</surname><given-names>A</given-names></name><name><surname>Wilkinson</surname><given-names>AC</given-names></name><name><surname>Sankaran</surname><given-names>VG</given-names></name><name><surname>Cvejic</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Exploiting somatic mutations to decipher human blood production: a natural lineage-tracing strategy</article-title><source>Experimental Hematology</source><volume>121</volume><fpage>2</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1016/j.exphem.2023.01.005</pub-id><pub-id pub-id-type="pmid">36736573</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bomans</surname><given-names>K</given-names></name><name><surname>Schenz</surname><given-names>J</given-names></name><name><surname>Sztwiertnia</surname><given-names>I</given-names></name><name><surname>Schaack</surname><given-names>D</given-names></name><name><surname>Weigand</surname><given-names>MA</given-names></name><name><surname>Uhle</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Sepsis induces a long-lasting state of trained immunity in bone marrow monocytes</article-title><source>Frontiers in Immunology</source><volume>9</volume><elocation-id>2685</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2018.02685</pub-id><pub-id pub-id-type="pmid">30510555</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonora</surname><given-names>M</given-names></name><name><surname>Morganti</surname><given-names>C</given-names></name><name><surname>van Gastel</surname><given-names>N</given-names></name><name><surname>Ito</surname><given-names>K</given-names></name><name><surname>Calura</surname><given-names>E</given-names></name><name><surname>Zanolla</surname><given-names>I</given-names></name><name><surname>Ferroni</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Jung</surname><given-names>Y</given-names></name><name><surname>Sales</surname><given-names>G</given-names></name><name><surname>Martini</surname><given-names>P</given-names></name><name><surname>Nakamura</surname><given-names>T</given-names></name><name><surname>Lasorsa</surname><given-names>FM</given-names></name><name><surname>Finkel</surname><given-names>T</given-names></name><name><surname>Lin</surname><given-names>CP</given-names></name><name><surname>Zavan</surname><given-names>B</given-names></name><name><surname>Pinton</surname><given-names>P</given-names></name><name><surname>Georgakoudi</surname><given-names>I</given-names></name><name><surname>Romualdi</surname><given-names>C</given-names></name><name><surname>Scadden</surname><given-names>DT</given-names></name><name><surname>Ito</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>A mitochondrial NADPH-cholesterol axis regulates extracellular vesicle biogenesis to support hematopoietic stem cell fate</article-title><source>Cell Stem Cell</source><volume>31</volume><fpage>359</fpage><lpage>377</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2024.02.004</pub-id><pub-id pub-id-type="pmid">38458178</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Busch</surname><given-names>K</given-names></name><name><surname>Rodewald</surname><given-names>HR</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Unperturbed vs. post-transplantation hematopoiesis: both in vivo but different</article-title><source>Current Opinion in Hematology</source><volume>23</volume><fpage>295</fpage><lpage>303</lpage><pub-id pub-id-type="doi">10.1097/MOH.0000000000000250</pub-id><pub-id pub-id-type="pmid">27213498</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cabezas-Wallscheid</surname><given-names>N</given-names></name><name><surname>Klimmeck</surname><given-names>D</given-names></name><name><surname>Hansson</surname><given-names>J</given-names></name><name><surname>Lipka</surname><given-names>DB</given-names></name><name><surname>Reyes</surname><given-names>A</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Weichenhan</surname><given-names>D</given-names></name><name><surname>Lier</surname><given-names>A</given-names></name><name><surname>von Paleske</surname><given-names>L</given-names></name><name><surname>Renders</surname><given-names>S</given-names></name><name><surname>Wünsche</surname><given-names>P</given-names></name><name><surname>Zeisberger</surname><given-names>P</given-names></name><name><surname>Brocks</surname><given-names>D</given-names></name><name><surname>Gu</surname><given-names>L</given-names></name><name><surname>Herrmann</surname><given-names>C</given-names></name><name><surname>Haas</surname><given-names>S</given-names></name><name><surname>Essers</surname><given-names>MAG</given-names></name><name><surname>Brors</surname><given-names>B</given-names></name><name><surname>Eils</surname><given-names>R</given-names></name><name><surname>Huber</surname><given-names>W</given-names></name><name><surname>Milsom</surname><given-names>MD</given-names></name><name><surname>Plass</surname><given-names>C</given-names></name><name><surname>Krijgsveld</surname><given-names>J</given-names></name><name><surname>Trumpp</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Identification of regulatory networks in HSCs and their immediate progeny via integrated proteome, transcriptome, and DNA methylome analysis</article-title><source>Cell Stem Cell</source><volume>15</volume><fpage>507</fpage><lpage>522</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2014.07.005</pub-id><pub-id pub-id-type="pmid">25158935</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>R</given-names></name><name><surname>Thatavarty</surname><given-names>A</given-names></name><name><surname>King</surname><given-names>KY</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>Forged in the fire: Lasting impacts of inflammation on hematopoietic progenitors</article-title><source>Experimental Hematology</source><volume>134</volume><elocation-id>104215</elocation-id><pub-id pub-id-type="doi">10.1016/j.exphem.2024.104215</pub-id><pub-id pub-id-type="pmid">38580008</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Challen</surname><given-names>GA</given-names></name><name><surname>Boles</surname><given-names>N</given-names></name><name><surname>Lin</surname><given-names>KKY</given-names></name><name><surname>Goodell</surname><given-names>MA</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Mouse hematopoietic stem cell identification and analysis</article-title><source>Cytometry. Part A</source><volume>75</volume><fpage>14</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1002/cyto.a.20674</pub-id><pub-id pub-id-type="pmid">19023891</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Challen</surname><given-names>GA</given-names></name><name><surname>Pietras</surname><given-names>EM</given-names></name><name><surname>Wallscheid</surname><given-names>NC</given-names></name><name><surname>Signer</surname><given-names>RAJ</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Simplified murine multipotent progenitor isolation scheme: Establishing a consensus approach for multipotent progenitor identification</article-title><source>Experimental Hematology</source><volume>104</volume><fpage>55</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1016/j.exphem.2021.09.007</pub-id><pub-id pub-id-type="pmid">34648848</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chanut</surname><given-names>FJA</given-names></name><name><surname>Sanvito</surname><given-names>F</given-names></name><name><surname>Ferrari</surname><given-names>G</given-names></name><name><surname>Visigalli</surname><given-names>I</given-names></name><name><surname>Carriglio</surname><given-names>N</given-names></name><name><surname>Hernandez</surname><given-names>RJ</given-names></name><name><surname>Norata</surname><given-names>R</given-names></name><name><surname>Doglioni</surname><given-names>C</given-names></name><name><surname>Naldini</surname><given-names>L</given-names></name><name><surname>Cristofori</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Conditioning regimens in long-term pre-clinical studies to support development of ex vivo gene therapy: review of nonproliferative and proliferative changes</article-title><source>Human Gene Therapy</source><volume>32</volume><fpage>66</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1089/hum.2020.135</pub-id><pub-id pub-id-type="pmid">32883113</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chavakis</surname><given-names>T</given-names></name><name><surname>Wielockx</surname><given-names>B</given-names></name><name><surname>Hajishengallis</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Inflammatory modulation of hematopoiesis: linking trained immunity and clonal hematopoiesis with chronic disorders</article-title><source>Annual Review of Physiology</source><volume>84</volume><fpage>183</fpage><lpage>207</lpage><pub-id pub-id-type="doi">10.1146/annurev-physiol-052521-013627</pub-id><pub-id pub-id-type="pmid">34614373</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>SC</given-names></name><name><surname>Quintin</surname><given-names>J</given-names></name><name><surname>Cramer</surname><given-names>RA</given-names></name><name><surname>Shepardson</surname><given-names>KM</given-names></name><name><surname>Saeed</surname><given-names>S</given-names></name><name><surname>Kumar</surname><given-names>V</given-names></name><name><surname>Giamarellos-Bourboulis</surname><given-names>EJ</given-names></name><name><surname>Martens</surname><given-names>JHA</given-names></name><name><surname>Rao</surname><given-names>NA</given-names></name><name><surname>Aghajanirefah</surname><given-names>A</given-names></name><name><surname>Manjeri</surname><given-names>GR</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Ifrim</surname><given-names>DC</given-names></name><name><surname>Arts</surname><given-names>RJW</given-names></name><name><surname>van der Veer</surname><given-names>B</given-names></name><name><surname>Deen</surname><given-names>PMT</given-names></name><name><surname>Logie</surname><given-names>C</given-names></name><name><surname>O’Neill</surname><given-names>LA</given-names></name><name><surname>Willems</surname><given-names>P</given-names></name><name><surname>van de Veerdonk</surname><given-names>FL</given-names></name><name><surname>van der Meer</surname><given-names>JWM</given-names></name><name><surname>Ng</surname><given-names>A</given-names></name><name><surname>Joosten</surname><given-names>LAB</given-names></name><name><surname>Wijmenga</surname><given-names>C</given-names></name><name><surname>Stunnenberg</surname><given-names>HG</given-names></name><name><surname>Xavier</surname><given-names>RJ</given-names></name><name><surname>Netea</surname><given-names>MG</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>mTOR- and HIF-1α-mediated aerobic glycolysis as metabolic basis for trained immunity</article-title><source>Science</source><volume>345</volume><elocation-id>1250684</elocation-id><pub-id pub-id-type="doi">10.1126/science.1250684</pub-id><pub-id pub-id-type="pmid">25258083</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>H</given-names></name><name><surname>Zheng</surname><given-names>Z</given-names></name><name><surname>Cheng</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>New paradigms on hematopoietic stem cell differentiation</article-title><source>Protein &amp; Cell</source><volume>11</volume><fpage>34</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1007/s13238-019-0633-0</pub-id><pub-id pub-id-type="pmid">31201709</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheong</surname><given-names>JG</given-names></name><name><surname>Ravishankar</surname><given-names>A</given-names></name><name><surname>Sharma</surname><given-names>S</given-names></name><name><surname>Parkhurst</surname><given-names>CN</given-names></name><name><surname>Grassmann</surname><given-names>SA</given-names></name><name><surname>Wingert</surname><given-names>CK</given-names></name><name><surname>Laurent</surname><given-names>P</given-names></name><name><surname>Ma</surname><given-names>S</given-names></name><name><surname>Paddock</surname><given-names>L</given-names></name><name><surname>Miranda</surname><given-names>IC</given-names></name><name><surname>Karakaslar</surname><given-names>EO</given-names></name><name><surname>Nehar-Belaid</surname><given-names>D</given-names></name><name><surname>Thibodeau</surname><given-names>A</given-names></name><name><surname>Bale</surname><given-names>MJ</given-names></name><name><surname>Kartha</surname><given-names>VK</given-names></name><name><surname>Yee</surname><given-names>JK</given-names></name><name><surname>Mays</surname><given-names>MY</given-names></name><name><surname>Jiang</surname><given-names>C</given-names></name><name><surname>Daman</surname><given-names>AW</given-names></name><name><surname>Martinez de Paz</surname><given-names>A</given-names></name><name><surname>Ahimovic</surname><given-names>D</given-names></name><name><surname>Ramos</surname><given-names>V</given-names></name><name><surname>Lercher</surname><given-names>A</given-names></name><name><surname>Nielsen</surname><given-names>E</given-names></name><name><surname>Alvarez-Mulett</surname><given-names>S</given-names></name><name><surname>Zheng</surname><given-names>L</given-names></name><name><surname>Earl</surname><given-names>A</given-names></name><name><surname>Yallowitz</surname><given-names>A</given-names></name><name><surname>Robbins</surname><given-names>L</given-names></name><name><surname>LaFond</surname><given-names>E</given-names></name><name><surname>Weidman</surname><given-names>KL</given-names></name><name><surname>Racine-Brzostek</surname><given-names>S</given-names></name><name><surname>Yang</surname><given-names>HS</given-names></name><name><surname>Price</surname><given-names>DR</given-names></name><name><surname>Leyre</surname><given-names>L</given-names></name><name><surname>Rendeiro</surname><given-names>AF</given-names></name><name><surname>Ravichandran</surname><given-names>H</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Borczuk</surname><given-names>AC</given-names></name><name><surname>Rice</surname><given-names>CM</given-names></name><name><surname>Jones</surname><given-names>RB</given-names></name><name><surname>Schenck</surname><given-names>EJ</given-names></name><name><surname>Kaner</surname><given-names>RJ</given-names></name><name><surname>Chadburn</surname><given-names>A</given-names></name><name><surname>Zhao</surname><given-names>Z</given-names></name><name><surname>Pascual</surname><given-names>V</given-names></name><name><surname>Elemento</surname><given-names>O</given-names></name><name><surname>Schwartz</surname><given-names>RE</given-names></name><name><surname>Buenrostro</surname><given-names>JD</given-names></name><name><surname>Niec</surname><given-names>RE</given-names></name><name><surname>Barrat</surname><given-names>FJ</given-names></name><name><surname>Lief</surname><given-names>L</given-names></name><name><surname>Sun</surname><given-names>JC</given-names></name><name><surname>Ucar</surname><given-names>D</given-names></name><name><surname>Josefowicz</surname><given-names>SZ</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Epigenetic memory of coronavirus infection in innate immune cells and their progenitors</article-title><source>Cell</source><volume>186</volume><fpage>3882</fpage><lpage>3902</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2023.07.019</pub-id><pub-id pub-id-type="pmid">37597510</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Christ</surname><given-names>A</given-names></name><name><surname>Günther</surname><given-names>P</given-names></name><name><surname>Lauterbach</surname><given-names>MAR</given-names></name><name><surname>Duewell</surname><given-names>P</given-names></name><name><surname>Biswas</surname><given-names>D</given-names></name><name><surname>Pelka</surname><given-names>K</given-names></name><name><surname>Scholz</surname><given-names>CJ</given-names></name><name><surname>Oosting</surname><given-names>M</given-names></name><name><surname>Haendler</surname><given-names>K</given-names></name><name><surname>Baßler</surname><given-names>K</given-names></name><name><surname>Klee</surname><given-names>K</given-names></name><name><surname>Schulte-Schrepping</surname><given-names>J</given-names></name><name><surname>Ulas</surname><given-names>T</given-names></name><name><surname>Moorlag</surname><given-names>SJCFM</given-names></name><name><surname>Kumar</surname><given-names>V</given-names></name><name><surname>Park</surname><given-names>MH</given-names></name><name><surname>Joosten</surname><given-names>LAB</given-names></name><name><surname>Groh</surname><given-names>LA</given-names></name><name><surname>Riksen</surname><given-names>NP</given-names></name><name><surname>Espevik</surname><given-names>T</given-names></name><name><surname>Schlitzer</surname><given-names>A</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Fitzgerald</surname><given-names>ML</given-names></name><name><surname>Netea</surname><given-names>MG</given-names></name><name><surname>Schultze</surname><given-names>JL</given-names></name><name><surname>Latz</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Western diet triggers nlrp3-dependent innate immune reprogramming</article-title><source>Cell</source><volume>172</volume><fpage>162</fpage><lpage>175</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2017.12.013</pub-id><pub-id pub-id-type="pmid">29328911</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chung</surname><given-names>HY</given-names></name><name><surname>Sung</surname><given-names>B</given-names></name><name><surname>Jung</surname><given-names>KJ</given-names></name><name><surname>Zou</surname><given-names>Y</given-names></name><name><surname>Yu</surname><given-names>BP</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>The molecular inflammatory process in aging</article-title><source>Antioxidants &amp; Redox Signaling</source><volume>8</volume><fpage>572</fpage><lpage>581</lpage><pub-id pub-id-type="doi">10.1089/ars.2006.8.572</pub-id><pub-id pub-id-type="pmid">16677101</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ciarlo</surname><given-names>E</given-names></name><name><surname>Heinonen</surname><given-names>T</given-names></name><name><surname>Théroude</surname><given-names>C</given-names></name><name><surname>Asgari</surname><given-names>F</given-names></name><name><surname>Le Roy</surname><given-names>D</given-names></name><name><surname>Netea</surname><given-names>MG</given-names></name><name><surname>Roger</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Trained immunity confers broad-spectrum protection against bacterial infections</article-title><source>The Journal of Infectious Diseases</source><volume>222</volume><fpage>1869</fpage><lpage>1881</lpage><pub-id pub-id-type="doi">10.1093/infdis/jiz692</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cimato</surname><given-names>TR</given-names></name><name><surname>Furlage</surname><given-names>RL</given-names></name><name><surname>Conway</surname><given-names>A</given-names></name><name><surname>Wallace</surname><given-names>PK</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Simultaneous measurement of human hematopoietic stem and progenitor cells in blood using multicolor flow cytometry</article-title><source>Cytometry. Part B, Clinical Cytometry</source><volume>90</volume><fpage>415</fpage><lpage>423</lpage><pub-id pub-id-type="doi">10.1002/cyto.b.21354</pub-id><pub-id pub-id-type="pmid">26663713</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cirovic</surname><given-names>B</given-names></name><name><surname>de Bree</surname><given-names>LCJ</given-names></name><name><surname>Groh</surname><given-names>L</given-names></name><name><surname>Blok</surname><given-names>BA</given-names></name><name><surname>Chan</surname><given-names>J</given-names></name><name><surname>van der Velden</surname><given-names>W</given-names></name><name><surname>Bremmers</surname><given-names>MEJ</given-names></name><name><surname>van Crevel</surname><given-names>R</given-names></name><name><surname>Händler</surname><given-names>K</given-names></name><name><surname>Picelli</surname><given-names>S</given-names></name><name><surname>Schulte-Schrepping</surname><given-names>J</given-names></name><name><surname>Klee</surname><given-names>K</given-names></name><name><surname>Oosting</surname><given-names>M</given-names></name><name><surname>Koeken</surname><given-names>V</given-names></name><name><surname>van Ingen</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Benn</surname><given-names>CS</given-names></name><name><surname>Schultze</surname><given-names>JL</given-names></name><name><surname>Joosten</surname><given-names>LAB</given-names></name><name><surname>Curtis</surname><given-names>N</given-names></name><name><surname>Netea</surname><given-names>MG</given-names></name><name><surname>Schlitzer</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>BCG vaccination in humans elicits trained immunity via the hematopoietic progenitor compartment</article-title><source>Cell Host &amp; Microbe</source><volume>28</volume><fpage>322</fpage><lpage>334</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2020.05.014</pub-id><pub-id pub-id-type="pmid">32544459</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crosse</surname><given-names>EI</given-names></name><name><surname>Gordon-Keylock</surname><given-names>S</given-names></name><name><surname>Rybtsov</surname><given-names>S</given-names></name><name><surname>Binagui-Casas</surname><given-names>A</given-names></name><name><surname>Felchle</surname><given-names>H</given-names></name><name><surname>Nnadi</surname><given-names>NC</given-names></name><name><surname>Kirschner</surname><given-names>K</given-names></name><name><surname>Chandra</surname><given-names>T</given-names></name><name><surname>Tamagno</surname><given-names>S</given-names></name><name><surname>Webb</surname><given-names>DJ</given-names></name><name><surname>Rossi</surname><given-names>F</given-names></name><name><surname>Anderson</surname><given-names>RA</given-names></name><name><surname>Medvinsky</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Multi-layered Spatial transcriptomics identify secretory factors promoting human hematopoietic stem cell development</article-title><source>Cell Stem Cell</source><volume>27</volume><fpage>822</fpage><lpage>839</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2020.08.004</pub-id><pub-id pub-id-type="pmid">32946788</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cunningham</surname><given-names>KT</given-names></name><name><surname>Finlay</surname><given-names>CM</given-names></name><name><surname>Mills</surname><given-names>KHG</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Helminth imprinting of hematopoietic stem cells sustains anti-inflammatory trained innate immunity that attenuates autoimmune disease</article-title><source>Journal of Immunology</source><volume>206</volume><fpage>1618</fpage><lpage>1630</lpage><pub-id pub-id-type="pmid">33579723</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Laval</surname><given-names>B</given-names></name><name><surname>Maurizio</surname><given-names>J</given-names></name><name><surname>Kandalla</surname><given-names>PK</given-names></name><name><surname>Brisou</surname><given-names>G</given-names></name><name><surname>Simonnet</surname><given-names>L</given-names></name><name><surname>Huber</surname><given-names>C</given-names></name><name><surname>Gimenez</surname><given-names>G</given-names></name><name><surname>Matcovitch-Natan</surname><given-names>O</given-names></name><name><surname>Reinhardt</surname><given-names>S</given-names></name><name><surname>David</surname><given-names>E</given-names></name><name><surname>Mildner</surname><given-names>A</given-names></name><name><surname>Leutz</surname><given-names>A</given-names></name><name><surname>Nadel</surname><given-names>B</given-names></name><name><surname>Bordi</surname><given-names>C</given-names></name><name><surname>Amit</surname><given-names>I</given-names></name><name><surname>Sarrazin</surname><given-names>S</given-names></name><name><surname>Sieweke</surname><given-names>MH</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>C/EBPβ-Dependent epigenetic memory induces trained immunity in hematopoietic stem cells</article-title><source>Cell Stem Cell</source><volume>26</volume><fpage>657</fpage><lpage>674</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2020.01.017</pub-id><pub-id pub-id-type="pmid">32169166</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ding</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Liu</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Transcriptional and epigenetic control of hematopoietic stem cell fate decisions in vertebrates</article-title><source>Developmental Biology</source><volume>475</volume><fpage>156</fpage><lpage>164</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2021.03.003</pub-id><pub-id pub-id-type="pmid">33689804</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Domínguez-Andrés</surname><given-names>J</given-names></name><name><surname>Novakovic</surname><given-names>B</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Scicluna</surname><given-names>BP</given-names></name><name><surname>Gresnigt</surname><given-names>MS</given-names></name><name><surname>Arts</surname><given-names>RJW</given-names></name><name><surname>Oosting</surname><given-names>M</given-names></name><name><surname>Moorlag</surname><given-names>S</given-names></name><name><surname>Groh</surname><given-names>LA</given-names></name><name><surname>Zwaag</surname><given-names>J</given-names></name><name><surname>Koch</surname><given-names>RM</given-names></name><name><surname>Ter Horst</surname><given-names>R</given-names></name><name><surname>Joosten</surname><given-names>LAB</given-names></name><name><surname>Wijmenga</surname><given-names>C</given-names></name><name><surname>Michelucci</surname><given-names>A</given-names></name><name><surname>van der Poll</surname><given-names>T</given-names></name><name><surname>Kox</surname><given-names>M</given-names></name><name><surname>Pickkers</surname><given-names>P</given-names></name><name><surname>Kumar</surname><given-names>V</given-names></name><name><surname>Stunnenberg</surname><given-names>H</given-names></name><name><surname>Netea</surname><given-names>MG</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The itaconate pathway is a central regulatory node linking innate immune tolerance and trained immunity</article-title><source>Cell Metabolism</source><volume>29</volume><fpage>211</fpage><lpage>220</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2018.09.003</pub-id><pub-id pub-id-type="pmid">30293776</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ema</surname><given-names>H</given-names></name><name><surname>Morita</surname><given-names>Y</given-names></name><name><surname>Suda</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Heterogeneity and hierarchy of hematopoietic stem cells</article-title><source>Experimental Hematology</source><volume>42</volume><fpage>74</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1016/j.exphem.2013.11.004</pub-id><pub-id pub-id-type="pmid">24269919</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Essers</surname><given-names>MAG</given-names></name><name><surname>Offner</surname><given-names>S</given-names></name><name><surname>Blanco-Bose</surname><given-names>WE</given-names></name><name><surname>Waibler</surname><given-names>Z</given-names></name><name><surname>Kalinke</surname><given-names>U</given-names></name><name><surname>Duchosal</surname><given-names>MA</given-names></name><name><surname>Trumpp</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>IFNalpha activates dormant haematopoietic stem cells in vivo</article-title><source>Nature</source><volume>458</volume><fpage>904</fpage><lpage>908</lpage><pub-id pub-id-type="doi">10.1038/nature07815</pub-id><pub-id pub-id-type="pmid">19212321</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferreira</surname><given-names>AV</given-names></name><name><surname>Domínguez-Andrés</surname><given-names>J</given-names></name><name><surname>Merlo Pich</surname><given-names>LM</given-names></name><name><surname>Joosten</surname><given-names>LAB</given-names></name><name><surname>Netea</surname><given-names>MG</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>Metabolic regulation in the induction of trained immunity</article-title><source>Seminars in Immunopathology</source><volume>46</volume><elocation-id>7</elocation-id><pub-id pub-id-type="doi">10.1007/s00281-024-01015-8</pub-id><pub-id pub-id-type="pmid">39060761</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Florez</surname><given-names>MA</given-names></name><name><surname>Tran</surname><given-names>BT</given-names></name><name><surname>Wathan</surname><given-names>TK</given-names></name><name><surname>DeGregori</surname><given-names>J</given-names></name><name><surname>Pietras</surname><given-names>EM</given-names></name><name><surname>King</surname><given-names>KY</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Clonal hematopoiesis: Mutation-specific adaptation to environmental change</article-title><source>Cell Stem Cell</source><volume>29</volume><fpage>882</fpage><lpage>904</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2022.05.006</pub-id><pub-id pub-id-type="pmid">35659875</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flynn</surname><given-names>JL</given-names></name><name><surname>Chan</surname><given-names>J</given-names></name><name><surname>Triebold</surname><given-names>KJ</given-names></name><name><surname>Dalton</surname><given-names>DK</given-names></name><name><surname>Stewart</surname><given-names>TA</given-names></name><name><surname>Bloom</surname><given-names>BR</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>An essential role for interferon gamma in resistance to <italic>Mycobacterium tuberculosis</italic> infection</article-title><source>The Journal of Experimental Medicine</source><volume>178</volume><fpage>2249</fpage><lpage>2254</lpage><pub-id pub-id-type="doi">10.1084/jem.178.6.2249</pub-id><pub-id pub-id-type="pmid">7504064</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gekas</surname><given-names>C</given-names></name><name><surname>Graf</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>CD41 expression marks myeloid-biased adult hematopoietic stem cells and increases with age</article-title><source>Blood</source><volume>121</volume><fpage>4463</fpage><lpage>4472</lpage><pub-id pub-id-type="doi">10.1182/blood-2012-09-457929</pub-id><pub-id pub-id-type="pmid">23564910</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geller</surname><given-names>AE</given-names></name><name><surname>Shrestha</surname><given-names>R</given-names></name><name><surname>Woeste</surname><given-names>MR</given-names></name><name><surname>Guo</surname><given-names>H</given-names></name><name><surname>Hu</surname><given-names>X</given-names></name><name><surname>Ding</surname><given-names>C</given-names></name><name><surname>Andreeva</surname><given-names>K</given-names></name><name><surname>Chariker</surname><given-names>JH</given-names></name><name><surname>Zhou</surname><given-names>M</given-names></name><name><surname>Tieri</surname><given-names>D</given-names></name><name><surname>Watson</surname><given-names>CT</given-names></name><name><surname>Mitchell</surname><given-names>RA</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Martin II</surname><given-names>RCG</given-names></name><name><surname>Rouchka</surname><given-names>EC</given-names></name><name><surname>Yan</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>The induction of peripheral trained immunity in the pancreas incites anti-tumor activity to control pancreatic cancer progression</article-title><source>Nature Communications</source><volume>13</volume><elocation-id>759</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-022-28407-4</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gow</surname><given-names>NAR</given-names></name><name><surname>Netea</surname><given-names>MG</given-names></name><name><surname>Munro</surname><given-names>CA</given-names></name><name><surname>Ferwerda</surname><given-names>G</given-names></name><name><surname>Bates</surname><given-names>S</given-names></name><name><surname>Mora-Montes</surname><given-names>HM</given-names></name><name><surname>Walker</surname><given-names>L</given-names></name><name><surname>Jansen</surname><given-names>T</given-names></name><name><surname>Jacobs</surname><given-names>L</given-names></name><name><surname>Tsoni</surname><given-names>V</given-names></name><name><surname>Brown</surname><given-names>GD</given-names></name><name><surname>Odds</surname><given-names>FC</given-names></name><name><surname>Van der Meer</surname><given-names>JWM</given-names></name><name><surname>Brown</surname><given-names>AJP</given-names></name><name><surname>Kullberg</surname><given-names>BJ</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Immune recognition of Candida albicans beta-glucan by dectin-1</article-title><source>The Journal of Infectious Diseases</source><volume>196</volume><fpage>1565</fpage><lpage>1571</lpage><pub-id pub-id-type="doi">10.1086/523110</pub-id><pub-id pub-id-type="pmid">18008237</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Granick</surname><given-names>JL</given-names></name><name><surname>Simon</surname><given-names>SI</given-names></name><name><surname>Borjesson</surname><given-names>DL</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Hematopoietic stem and progenitor cells as effectors in innate immunity</article-title><source>Bone Marrow Research</source><volume>2012</volume><elocation-id>165107</elocation-id><pub-id pub-id-type="doi">10.1155/2012/165107</pub-id><pub-id pub-id-type="pmid">22762001</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hasan</surname><given-names>T</given-names></name><name><surname>Pasala</surname><given-names>AR</given-names></name><name><surname>Hassan</surname><given-names>D</given-names></name><name><surname>Hanotaux</surname><given-names>J</given-names></name><name><surname>Allan</surname><given-names>DS</given-names></name><name><surname>Maganti</surname><given-names>HB</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>Homing and engraftment of hematopoietic stem cells following transplantation: a pre-clinical perspective</article-title><source>Current Oncology</source><volume>31</volume><fpage>603</fpage><lpage>616</lpage><pub-id pub-id-type="doi">10.3390/curroncol31020044</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hernández-Malmierca</surname><given-names>P</given-names></name><name><surname>Vonficht</surname><given-names>D</given-names></name><name><surname>Schnell</surname><given-names>A</given-names></name><name><surname>Uckelmann</surname><given-names>HJ</given-names></name><name><surname>Bollhagen</surname><given-names>A</given-names></name><name><surname>Mahmoud</surname><given-names>MAA</given-names></name><name><surname>Landua</surname><given-names>SL</given-names></name><name><surname>van der Salm</surname><given-names>E</given-names></name><name><surname>Trautmann</surname><given-names>CL</given-names></name><name><surname>Raffel</surname><given-names>S</given-names></name><name><surname>Grünschläger</surname><given-names>F</given-names></name><name><surname>Lutz</surname><given-names>R</given-names></name><name><surname>Ghosh</surname><given-names>M</given-names></name><name><surname>Renders</surname><given-names>S</given-names></name><name><surname>Correia</surname><given-names>N</given-names></name><name><surname>Donato</surname><given-names>E</given-names></name><name><surname>Dixon</surname><given-names>KO</given-names></name><name><surname>Hirche</surname><given-names>C</given-names></name><name><surname>Andresen</surname><given-names>C</given-names></name><name><surname>Robens</surname><given-names>C</given-names></name><name><surname>Werner</surname><given-names>PS</given-names></name><name><surname>Boch</surname><given-names>T</given-names></name><name><surname>Eisel</surname><given-names>D</given-names></name><name><surname>Osen</surname><given-names>W</given-names></name><name><surname>Pilz</surname><given-names>F</given-names></name><name><surname>Przybylla</surname><given-names>A</given-names></name><name><surname>Klein</surname><given-names>C</given-names></name><name><surname>Buchholz</surname><given-names>F</given-names></name><name><surname>Milsom</surname><given-names>MD</given-names></name><name><surname>Essers</surname><given-names>MAG</given-names></name><name><surname>Eichmüller</surname><given-names>SB</given-names></name><name><surname>Hofmann</surname><given-names>WK</given-names></name><name><surname>Nowak</surname><given-names>D</given-names></name><name><surname>Hübschmann</surname><given-names>D</given-names></name><name><surname>Hundemer</surname><given-names>M</given-names></name><name><surname>Thiede</surname><given-names>C</given-names></name><name><surname>Bullinger</surname><given-names>L</given-names></name><name><surname>Müller-Tidow</surname><given-names>C</given-names></name><name><surname>Armstrong</surname><given-names>SA</given-names></name><name><surname>Trumpp</surname><given-names>A</given-names></name><name><surname>Kuchroo</surname><given-names>VK</given-names></name><name><surname>Haas</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Antigen presentation safeguards the integrity of the hematopoietic stem cell pool</article-title><source>Cell Stem Cell</source><volume>29</volume><fpage>760</fpage><lpage>775</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2022.04.007</pub-id><pub-id pub-id-type="pmid">35523139</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hersh</surname><given-names>EM</given-names></name><name><surname>Gutterman</surname><given-names>JU</given-names></name><name><surname>Mavligit</surname><given-names>GM</given-names></name></person-group><year iso-8601-date="1977">1977</year><article-title>BCG as adjuvant immunotherapy for neoplasia</article-title><source>Annual Review of Medicine</source><volume>28</volume><fpage>489</fpage><lpage>515</lpage><pub-id pub-id-type="doi">10.1146/annurev.me.28.020177.002421</pub-id><pub-id pub-id-type="pmid">324372</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hinge</surname><given-names>A</given-names></name><name><surname>He</surname><given-names>J</given-names></name><name><surname>Bartram</surname><given-names>J</given-names></name><name><surname>Javier</surname><given-names>J</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Fjellman</surname><given-names>E</given-names></name><name><surname>Sesaki</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>T</given-names></name><name><surname>Yu</surname><given-names>J</given-names></name><name><surname>Wunderlich</surname><given-names>M</given-names></name><name><surname>Mulloy</surname><given-names>J</given-names></name><name><surname>Kofron</surname><given-names>M</given-names></name><name><surname>Salomonis</surname><given-names>N</given-names></name><name><surname>Grimes</surname><given-names>HL</given-names></name><name><surname>Filippi</surname><given-names>MD</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Asymmetrically segregated mitochondria provide cellular memory of hematopoietic stem cell replicative history and drive HSC attrition</article-title><source>Cell Stem Cell</source><volume>26</volume><fpage>420</fpage><lpage>430</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2020.01.016</pub-id><pub-id pub-id-type="pmid">32059807</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Höfer</surname><given-names>T</given-names></name><name><surname>Rodewald</surname><given-names>H-R</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Differentiation-based model of hematopoietic stem cell functions and lineage pathways</article-title><source>Blood</source><volume>132</volume><fpage>1106</fpage><lpage>1113</lpage><pub-id pub-id-type="doi">10.1182/blood-2018-03-791517</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hormaechea-Agulla</surname><given-names>D</given-names></name><name><surname>Matatall</surname><given-names>KA</given-names></name><name><surname>Le</surname><given-names>DT</given-names></name><name><surname>Kain</surname><given-names>B</given-names></name><name><surname>Long</surname><given-names>X</given-names></name><name><surname>Kus</surname><given-names>P</given-names></name><name><surname>Jaksik</surname><given-names>R</given-names></name><name><surname>Challen</surname><given-names>GA</given-names></name><name><surname>Kimmel</surname><given-names>M</given-names></name><name><surname>King</surname><given-names>KY</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Chronic infection drives Dnmt3a-loss-of-function clonal hematopoiesis via IFNγ signaling</article-title><source>Cell Stem Cell</source><volume>28</volume><fpage>1428</fpage><lpage>1442</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2021.03.002</pub-id><pub-id pub-id-type="pmid">33743191</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jaiswal</surname><given-names>S</given-names></name><name><surname>Ebert</surname><given-names>BL</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Clonal hematopoiesis in human aging and disease</article-title><source>Science</source><volume>366</volume><elocation-id>eaan4673</elocation-id><pub-id pub-id-type="doi">10.1126/science.aan4673</pub-id><pub-id pub-id-type="pmid">31672865</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jentho</surname><given-names>E</given-names></name><name><surname>Ruiz-Moreno</surname><given-names>C</given-names></name><name><surname>Novakovic</surname><given-names>B</given-names></name><name><surname>Kourtzelis</surname><given-names>I</given-names></name><name><surname>Megchelenbrink</surname><given-names>WL</given-names></name><name><surname>Martins</surname><given-names>R</given-names></name><name><surname>Chavakis</surname><given-names>T</given-names></name><name><surname>Soares</surname><given-names>MP</given-names></name><name><surname>Kalafati</surname><given-names>L</given-names></name><name><surname>Guerra</surname><given-names>J</given-names></name><name><surname>Roestel</surname><given-names>F</given-names></name><name><surname>Bohm</surname><given-names>P</given-names></name><name><surname>Godmann</surname><given-names>M</given-names></name><name><surname>Grinenko</surname><given-names>T</given-names></name><name><surname>Eugster</surname><given-names>A</given-names></name><name><surname>Beretta</surname><given-names>M</given-names></name><name><surname>Joosten</surname><given-names>LAB</given-names></name><name><surname>Netea</surname><given-names>MG</given-names></name><name><surname>Bauer</surname><given-names>M</given-names></name><name><surname>Stunnenberg</surname><given-names>HG</given-names></name><name><surname>Weis</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Trained innate immunity, long-lasting epigenetic modulation, and skewed myelopoiesis by heme</article-title><source>PNAS</source><volume>118</volume><elocation-id>e2102698118</elocation-id><pub-id pub-id-type="doi">10.1073/pnas.2102698118</pub-id><pub-id pub-id-type="pmid">34663697</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johansson</surname><given-names>A</given-names></name><name><surname>Lin</surname><given-names>DS</given-names></name><name><surname>Mercier</surname><given-names>FE</given-names></name><name><surname>Yamashita</surname><given-names>M</given-names></name><name><surname>Divangahi</surname><given-names>M</given-names></name><name><surname>Sieweke</surname><given-names>MH</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Trained immunity and epigenetic memory in long-term self-renewing hematopoietic cells</article-title><source>Experimental Hematology</source><volume>121</volume><fpage>6</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1016/j.exphem.2023.02.001</pub-id><pub-id pub-id-type="pmid">36764598</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kain</surname><given-names>BN</given-names></name><name><surname>Tran</surname><given-names>BT</given-names></name><name><surname>Luna</surname><given-names>PN</given-names></name><name><surname>Cao</surname><given-names>R</given-names></name><name><surname>Le</surname><given-names>DT</given-names></name><name><surname>Florez</surname><given-names>MA</given-names></name><name><surname>Maneix</surname><given-names>L</given-names></name><name><surname>Toups</surname><given-names>JD</given-names></name><name><surname>Morales-Mantilla</surname><given-names>DE</given-names></name><name><surname>Koh</surname><given-names>S</given-names></name><name><surname>Han</surname><given-names>H</given-names></name><name><surname>Jaksik</surname><given-names>R</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Catic</surname><given-names>A</given-names></name><name><surname>Shaw</surname><given-names>CA</given-names></name><name><surname>King</surname><given-names>KY</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Hematopoietic stem and progenitor cells confer cross-protective trained immunity in mouse models</article-title><source>iScience</source><volume>26</volume><elocation-id>107596</elocation-id><pub-id pub-id-type="doi">10.1016/j.isci.2023.107596</pub-id><pub-id pub-id-type="pmid">37664586</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalafati</surname><given-names>L</given-names></name><name><surname>Kourtzelis</surname><given-names>I</given-names></name><name><surname>Schulte-Schrepping</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Hatzioannou</surname><given-names>A</given-names></name><name><surname>Grinenko</surname><given-names>T</given-names></name><name><surname>Hagag</surname><given-names>E</given-names></name><name><surname>Sinha</surname><given-names>A</given-names></name><name><surname>Has</surname><given-names>C</given-names></name><name><surname>Dietz</surname><given-names>S</given-names></name><name><surname>de Jesus Domingues</surname><given-names>AM</given-names></name><name><surname>Nati</surname><given-names>M</given-names></name><name><surname>Sormendi</surname><given-names>S</given-names></name><name><surname>Neuwirth</surname><given-names>A</given-names></name><name><surname>Chatzigeorgiou</surname><given-names>A</given-names></name><name><surname>Ziogas</surname><given-names>A</given-names></name><name><surname>Lesche</surname><given-names>M</given-names></name><name><surname>Dahl</surname><given-names>A</given-names></name><name><surname>Henry</surname><given-names>I</given-names></name><name><surname>Subramanian</surname><given-names>P</given-names></name><name><surname>Wielockx</surname><given-names>B</given-names></name><name><surname>Murray</surname><given-names>P</given-names></name><name><surname>Mirtschink</surname><given-names>P</given-names></name><name><surname>Chung</surname><given-names>KJ</given-names></name><name><surname>Schultze</surname><given-names>JL</given-names></name><name><surname>Netea</surname><given-names>MG</given-names></name><name><surname>Hajishengallis</surname><given-names>G</given-names></name><name><surname>Verginis</surname><given-names>P</given-names></name><name><surname>Mitroulis</surname><given-names>I</given-names></name><name><surname>Chavakis</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Innate immune training of granulopoiesis promotes anti-tumor activity</article-title><source>Cell</source><volume>183</volume><fpage>771</fpage><lpage>785</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2020.09.058</pub-id><pub-id pub-id-type="pmid">33125892</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamada</surname><given-names>R</given-names></name><name><surname>Yang</surname><given-names>W</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Patel</surname><given-names>MC</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Ouda</surname><given-names>R</given-names></name><name><surname>Dey</surname><given-names>A</given-names></name><name><surname>Wakabayashi</surname><given-names>Y</given-names></name><name><surname>Sakaguchi</surname><given-names>K</given-names></name><name><surname>Fujita</surname><given-names>T</given-names></name><name><surname>Tamura</surname><given-names>T</given-names></name><name><surname>Zhu</surname><given-names>J</given-names></name><name><surname>Ozato</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Interferon stimulation creates chromatin marks and establishes transcriptional memory</article-title><source>PNAS</source><volume>115</volume><fpage>E9162</fpage><lpage>E9171</lpage><pub-id pub-id-type="doi">10.1073/pnas.1720930115</pub-id><pub-id pub-id-type="pmid">30201712</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>YA</given-names></name><name><surname>Paik</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>SY</given-names></name><name><surname>Chen</surname><given-names>JJ</given-names></name><name><surname>Olson</surname><given-names>OC</given-names></name><name><surname>Mitchell</surname><given-names>CA</given-names></name><name><surname>Collins</surname><given-names>A</given-names></name><name><surname>Swann</surname><given-names>JW</given-names></name><name><surname>Warr</surname><given-names>MR</given-names></name><name><surname>Fan</surname><given-names>R</given-names></name><name><surname>Passegué</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Secretory MPP3 reinforce myeloid differentiation trajectory and amplify myeloid cell production</article-title><source>The Journal of Experimental Medicine</source><volume>220</volume><elocation-id>e20230088</elocation-id><pub-id pub-id-type="doi">10.1084/jem.20230088</pub-id><pub-id pub-id-type="pmid">37115584</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>M</given-names></name><name><surname>Park</surname><given-names>HK</given-names></name><name><surname>Kim</surname><given-names>KS</given-names></name><name><surname>Choi</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>Animal models for transplant immunology: bridging bench to bedside</article-title><source>Clinical Transplantation and Research</source><volume>38</volume><fpage>354</fpage><lpage>376</lpage><pub-id pub-id-type="doi">10.4285/ctr.24.0029</pub-id><pub-id pub-id-type="pmid">39233453</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaufmann</surname><given-names>E</given-names></name><name><surname>Sanz</surname><given-names>J</given-names></name><name><surname>Dunn</surname><given-names>JL</given-names></name><name><surname>Khan</surname><given-names>N</given-names></name><name><surname>Mendonça</surname><given-names>LE</given-names></name><name><surname>Pacis</surname><given-names>A</given-names></name><name><surname>Tzelepis</surname><given-names>F</given-names></name><name><surname>Pernet</surname><given-names>E</given-names></name><name><surname>Dumaine</surname><given-names>A</given-names></name><name><surname>Grenier</surname><given-names>JC</given-names></name><name><surname>Mailhot-Léonard</surname><given-names>F</given-names></name><name><surname>Ahmed</surname><given-names>E</given-names></name><name><surname>Belle</surname><given-names>J</given-names></name><name><surname>Besla</surname><given-names>R</given-names></name><name><surname>Mazer</surname><given-names>B</given-names></name><name><surname>King</surname><given-names>IL</given-names></name><name><surname>Nijnik</surname><given-names>A</given-names></name><name><surname>Robbins</surname><given-names>CS</given-names></name><name><surname>Barreiro</surname><given-names>LB</given-names></name><name><surname>Divangahi</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>BCG educates hematopoietic stem cells to generate protective innate immunity against Tuberculosis</article-title><source>Cell</source><volume>172</volume><fpage>176</fpage><lpage>190</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2017.12.031</pub-id><pub-id pub-id-type="pmid">29328912</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaufmann</surname><given-names>E</given-names></name><name><surname>Khan</surname><given-names>N</given-names></name><name><surname>Tran</surname><given-names>KA</given-names></name><name><surname>Ulndreaj</surname><given-names>A</given-names></name><name><surname>Pernet</surname><given-names>E</given-names></name><name><surname>Fontes</surname><given-names>G</given-names></name><name><surname>Lupien</surname><given-names>A</given-names></name><name><surname>Desmeules</surname><given-names>P</given-names></name><name><surname>McIntosh</surname><given-names>F</given-names></name><name><surname>Abow</surname><given-names>A</given-names></name><name><surname>Moorlag</surname><given-names>SJCFM</given-names></name><name><surname>Debisarun</surname><given-names>P</given-names></name><name><surname>Mossman</surname><given-names>K</given-names></name><name><surname>Banerjee</surname><given-names>A</given-names></name><name><surname>Karo-Atar</surname><given-names>D</given-names></name><name><surname>Sadeghi</surname><given-names>M</given-names></name><name><surname>Mubareka</surname><given-names>S</given-names></name><name><surname>Vinh</surname><given-names>DC</given-names></name><name><surname>King</surname><given-names>IL</given-names></name><name><surname>Robbins</surname><given-names>CS</given-names></name><name><surname>Behr</surname><given-names>MA</given-names></name><name><surname>Netea</surname><given-names>MG</given-names></name><name><surname>Joubert</surname><given-names>P</given-names></name><name><surname>Divangahi</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>BCG vaccination provides protection against IAV but not SARS-CoV-2</article-title><source>Cell Reports</source><volume>38</volume><elocation-id>110502</elocation-id><pub-id pub-id-type="doi">10.1016/j.celrep.2022.110502</pub-id><pub-id pub-id-type="pmid">35235831</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>N</given-names></name><name><surname>Downey</surname><given-names>J</given-names></name><name><surname>Sanz</surname><given-names>J</given-names></name><name><surname>Kaufmann</surname><given-names>E</given-names></name><name><surname>Blankenhaus</surname><given-names>B</given-names></name><name><surname>Pacis</surname><given-names>A</given-names></name><name><surname>Pernet</surname><given-names>E</given-names></name><name><surname>Ahmed</surname><given-names>E</given-names></name><name><surname>Cardoso</surname><given-names>S</given-names></name><name><surname>Nijnik</surname><given-names>A</given-names></name><name><surname>Mazer</surname><given-names>B</given-names></name><name><surname>Sassetti</surname><given-names>C</given-names></name><name><surname>Behr</surname><given-names>MA</given-names></name><name><surname>Soares</surname><given-names>MP</given-names></name><name><surname>Barreiro</surname><given-names>LB</given-names></name><name><surname>Divangahi</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title><italic>M. tuberculosis</italic> reprograms hematopoietic stem cells to limit myelopoiesis and impair trained immunity</article-title><source>Cell</source><volume>183</volume><fpage>752</fpage><lpage>770</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2020.09.062</pub-id><pub-id pub-id-type="pmid">33125891</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>N</given-names></name><name><surname>Tran</surname><given-names>KA</given-names></name><name><surname>Chevre</surname><given-names>R</given-names></name><name><surname>Locher</surname><given-names>V</given-names></name><name><surname>Richter</surname><given-names>M</given-names></name><name><surname>Sun</surname><given-names>S</given-names></name><name><surname>Sadeghi</surname><given-names>M</given-names></name><name><surname>Pernet</surname><given-names>E</given-names></name><name><surname>Herrero-Cervera</surname><given-names>A</given-names></name><name><surname>Grant</surname><given-names>A</given-names></name><name><surname>Saif</surname><given-names>A</given-names></name><name><surname>Downey</surname><given-names>J</given-names></name><name><surname>Kaufmann</surname><given-names>E</given-names></name><name><surname>Khader</surname><given-names>SA</given-names></name><name><surname>Joubert</surname><given-names>P</given-names></name><name><surname>Barreiro</surname><given-names>LB</given-names></name><name><surname>Yipp</surname><given-names>BG</given-names></name><name><surname>Soehnlein</surname><given-names>O</given-names></name><name><surname>Divangahi</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2025">2025</year><article-title>β-Glucan reprograms neutrophils to promote disease tolerance against influenza A virus</article-title><source>Nature Immunology</source><volume>26</volume><fpage>174</fpage><lpage>187</lpage><pub-id pub-id-type="doi">10.1038/s41590-024-02041-2</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>King</surname><given-names>KY</given-names></name><name><surname>Goodell</surname><given-names>MA</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Inflammatory modulation of HSCs: viewing the HSC as a foundation for the immune response</article-title><source>Nature Reviews. Immunology</source><volume>11</volume><fpage>685</fpage><lpage>692</lpage><pub-id pub-id-type="doi">10.1038/nri3062</pub-id><pub-id pub-id-type="pmid">21904387</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kleinnijenhuis</surname><given-names>J</given-names></name><name><surname>Quintin</surname><given-names>J</given-names></name><name><surname>Preijers</surname><given-names>F</given-names></name><name><surname>Benn</surname><given-names>CS</given-names></name><name><surname>Joosten</surname><given-names>LAB</given-names></name><name><surname>Jacobs</surname><given-names>C</given-names></name><name><surname>van Loenhout</surname><given-names>J</given-names></name><name><surname>Xavier</surname><given-names>RJ</given-names></name><name><surname>Aaby</surname><given-names>P</given-names></name><name><surname>van der Meer</surname><given-names>JWM</given-names></name><name><surname>van Crevel</surname><given-names>R</given-names></name><name><surname>Netea</surname><given-names>MG</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Long-lasting effects of BCG vaccination on both heterologous Th1/Th17 responses and innate trained immunity</article-title><source>Journal of Innate Immunity</source><volume>6</volume><fpage>152</fpage><lpage>158</lpage><pub-id pub-id-type="doi">10.1159/000355628</pub-id><pub-id pub-id-type="pmid">24192057</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Larsen</surname><given-names>SB</given-names></name><name><surname>Cowley</surname><given-names>CJ</given-names></name><name><surname>Fuchs</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2020">2020a</year><article-title>Epithelial cells: liaisons of immunity</article-title><source>Current Opinion in Immunology</source><volume>62</volume><fpage>45</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1016/j.coi.2019.11.004</pub-id><pub-id pub-id-type="pmid">31874430</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Larsen</surname><given-names>ES</given-names></name><name><surname>Joensen</surname><given-names>UN</given-names></name><name><surname>Poulsen</surname><given-names>AM</given-names></name><name><surname>Goletti</surname><given-names>D</given-names></name><name><surname>Johansen</surname><given-names>IS</given-names></name></person-group><year iso-8601-date="2020">2020b</year><article-title>Bacillus Calmette-Guérin immunotherapy for bladder cancer: a review of immunological aspects, clinical effects and BCG infections</article-title><source>APMIS</source><volume>128</volume><fpage>92</fpage><lpage>103</lpage><pub-id pub-id-type="doi">10.1111/apm.13011</pub-id><pub-id pub-id-type="pmid">31755155</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Le</surname><given-names>DT</given-names></name><name><surname>Florez</surname><given-names>MA</given-names></name><name><surname>Kus</surname><given-names>P</given-names></name><name><surname>Tran</surname><given-names>BT</given-names></name><name><surname>Kain</surname><given-names>B</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Christensen</surname><given-names>K</given-names></name><name><surname>Jain</surname><given-names>A</given-names></name><name><surname>Malovannaya</surname><given-names>A</given-names></name><name><surname>King</surname><given-names>KY</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>BATF2 promotes HSC myeloid differentiation by amplifying IFN response mediators during chronic infection</article-title><source>iScience</source><volume>26</volume><elocation-id>106059</elocation-id><pub-id pub-id-type="doi">10.1016/j.isci.2023.106059</pub-id><pub-id pub-id-type="pmid">36824275</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Yu</surname><given-names>X</given-names></name><name><surname>Saha</surname><given-names>G</given-names></name><name><surname>Kalafati</surname><given-names>L</given-names></name><name><surname>Ioannidis</surname><given-names>C</given-names></name><name><surname>Mitroulis</surname><given-names>I</given-names></name><name><surname>Netea</surname><given-names>MG</given-names></name><name><surname>Chavakis</surname><given-names>T</given-names></name><name><surname>Hajishengallis</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Maladaptive innate immune training of myelopoiesis links inflammatory comorbidities</article-title><source>Cell</source><volume>185</volume><fpage>1709</fpage><lpage>1727</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2022.03.043</pub-id><pub-id pub-id-type="pmid">35483374</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Bowling</surname><given-names>S</given-names></name><name><surname>McGeary</surname><given-names>SE</given-names></name><name><surname>Yu</surname><given-names>Q</given-names></name><name><surname>Lemke</surname><given-names>B</given-names></name><name><surname>Alcedo</surname><given-names>K</given-names></name><name><surname>Jia</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Ferreira</surname><given-names>M</given-names></name><name><surname>Klein</surname><given-names>AM</given-names></name><name><surname>Wang</surname><given-names>SW</given-names></name><name><surname>Camargo</surname><given-names>FD</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>A mouse model with high clonal barcode diversity for joint lineage, transcriptomic, and epigenomic profiling in single cells</article-title><source>Cell</source><volume>186</volume><fpage>5183</fpage><lpage>5199</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2023.09.019</pub-id><pub-id pub-id-type="pmid">37852258</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liebermann</surname><given-names>DA</given-names></name><name><surname>Gregory</surname><given-names>B</given-names></name><name><surname>Hoffman</surname><given-names>B</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>AP-1 (Fos/Jun) transcription factors in hematopoietic differentiation and apoptosis</article-title><source>International Journal of Oncology</source><volume>12</volume><fpage>685</fpage><lpage>700</lpage><pub-id pub-id-type="doi">10.3892/ijo.12.3.685</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matatall</surname><given-names>KA</given-names></name><name><surname>Shen</surname><given-names>C-C</given-names></name><name><surname>Challen</surname><given-names>GA</given-names></name><name><surname>King</surname><given-names>KY</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Type II interferon promotes differentiation of myeloid-biased hematopoietic stem cells</article-title><source>Stem Cells</source><volume>32</volume><fpage>3023</fpage><lpage>3030</lpage><pub-id pub-id-type="doi">10.1002/stem.1799</pub-id><pub-id pub-id-type="pmid">25078851</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matatall</surname><given-names>KA</given-names></name><name><surname>Jeong</surname><given-names>M</given-names></name><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Sun</surname><given-names>D</given-names></name><name><surname>Chen</surname><given-names>F</given-names></name><name><surname>Mo</surname><given-names>Q</given-names></name><name><surname>Kimmel</surname><given-names>M</given-names></name><name><surname>King</surname><given-names>KY</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Chronic infection depletes hematopoietic stem cells through stress-induced terminal differentiation</article-title><source>Cell Reports</source><volume>17</volume><fpage>2584</fpage><lpage>2595</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2016.11.031</pub-id><pub-id pub-id-type="pmid">27926863</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mende</surname><given-names>N</given-names></name><name><surname>Laurenti</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Hematopoietic stem and progenitor cells outside the bone marrow: where, when, and why</article-title><source>Experimental Hematology</source><volume>104</volume><fpage>9</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1016/j.exphem.2021.10.002</pub-id><pub-id pub-id-type="pmid">34687807</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mills</surname><given-names>TS</given-names></name><name><surname>Kain</surname><given-names>B</given-names></name><name><surname>Burchill</surname><given-names>MA</given-names></name><name><surname>Danis</surname><given-names>E</given-names></name><name><surname>Lucas</surname><given-names>ED</given-names></name><name><surname>Culp-Hill</surname><given-names>R</given-names></name><name><surname>Cowan</surname><given-names>CM</given-names></name><name><surname>Schleicher</surname><given-names>WE</given-names></name><name><surname>Patel</surname><given-names>SB</given-names></name><name><surname>Tran</surname><given-names>BT</given-names></name><name><surname>Cao</surname><given-names>R</given-names></name><name><surname>Goodspeed</surname><given-names>A</given-names></name><name><surname>Ferrara</surname><given-names>S</given-names></name><name><surname>Bevers</surname><given-names>S</given-names></name><name><surname>Jirón Tamburini</surname><given-names>BA</given-names></name><name><surname>Roede</surname><given-names>JR</given-names></name><name><surname>D’Alessandro</surname><given-names>A</given-names></name><name><surname>King</surname><given-names>KY</given-names></name><name><surname>Pietras</surname><given-names>EM</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>A distinct metabolic and epigenetic state drives trained immunity in HSC-derived macrophages from autoimmune mice</article-title><source>Cell Stem Cell</source><volume>31</volume><fpage>1630</fpage><lpage>1649</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2024.09.010</pub-id><pub-id pub-id-type="pmid">39413777</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Missinato</surname><given-names>MA</given-names></name><name><surname>Murphy</surname><given-names>S</given-names></name><name><surname>Lynott</surname><given-names>M</given-names></name><name><surname>Yu</surname><given-names>MS</given-names></name><name><surname>Kervadec</surname><given-names>A</given-names></name><name><surname>Chang</surname><given-names>Y-L</given-names></name><name><surname>Kannan</surname><given-names>S</given-names></name><name><surname>Loreti</surname><given-names>M</given-names></name><name><surname>Lee</surname><given-names>C</given-names></name><name><surname>Amatya</surname><given-names>P</given-names></name><name><surname>Tanaka</surname><given-names>H</given-names></name><name><surname>Huang</surname><given-names>C-T</given-names></name><name><surname>Puri</surname><given-names>PL</given-names></name><name><surname>Kwon</surname><given-names>C</given-names></name><name><surname>Adams</surname><given-names>PD</given-names></name><name><surname>Qian</surname><given-names>L</given-names></name><name><surname>Sacco</surname><given-names>A</given-names></name><name><surname>Andersen</surname><given-names>P</given-names></name><name><surname>Colas</surname><given-names>AR</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Conserved transcription factors promote cell fate stability and restrict reprogramming potential in differentiated cells</article-title><source>Nature Communications</source><volume>14</volume><elocation-id>1709</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-023-37256-8</pub-id><pub-id pub-id-type="pmid">36973293</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitroulis</surname><given-names>I</given-names></name><name><surname>Ruppova</surname><given-names>K</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Chen</surname><given-names>LS</given-names></name><name><surname>Grzybek</surname><given-names>M</given-names></name><name><surname>Grinenko</surname><given-names>T</given-names></name><name><surname>Eugster</surname><given-names>A</given-names></name><name><surname>Troullinaki</surname><given-names>M</given-names></name><name><surname>Palladini</surname><given-names>A</given-names></name><name><surname>Kourtzelis</surname><given-names>I</given-names></name><name><surname>Chatzigeorgiou</surname><given-names>A</given-names></name><name><surname>Schlitzer</surname><given-names>A</given-names></name><name><surname>Beyer</surname><given-names>M</given-names></name><name><surname>Joosten</surname><given-names>LAB</given-names></name><name><surname>Isermann</surname><given-names>B</given-names></name><name><surname>Lesche</surname><given-names>M</given-names></name><name><surname>Petzold</surname><given-names>A</given-names></name><name><surname>Simons</surname><given-names>K</given-names></name><name><surname>Henry</surname><given-names>I</given-names></name><name><surname>Dahl</surname><given-names>A</given-names></name><name><surname>Schultze</surname><given-names>JL</given-names></name><name><surname>Wielockx</surname><given-names>B</given-names></name><name><surname>Zamboni</surname><given-names>N</given-names></name><name><surname>Mirtschink</surname><given-names>P</given-names></name><name><surname>Coskun</surname><given-names>Ü</given-names></name><name><surname>Hajishengallis</surname><given-names>G</given-names></name><name><surname>Netea</surname><given-names>MG</given-names></name><name><surname>Chavakis</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Modulation of myelopoiesis progenitors is an integral component of trained immunity</article-title><source>Cell</source><volume>172</volume><fpage>147</fpage><lpage>161</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2017.11.034</pub-id><pub-id pub-id-type="pmid">29328910</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitroulis</surname><given-names>I</given-names></name><name><surname>Kalafati</surname><given-names>L</given-names></name><name><surname>Bornhäuser</surname><given-names>M</given-names></name><name><surname>Hajishengallis</surname><given-names>G</given-names></name><name><surname>Chavakis</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Regulation of the bone marrow niche by inflammation</article-title><source>Frontiers in Immunology</source><volume>11</volume><elocation-id>1540</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2020.01540</pub-id><pub-id pub-id-type="pmid">32849521</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moorlag</surname><given-names>SJCFM</given-names></name><name><surname>Khan</surname><given-names>N</given-names></name><name><surname>Novakovic</surname><given-names>B</given-names></name><name><surname>Kaufmann</surname><given-names>E</given-names></name><name><surname>Jansen</surname><given-names>T</given-names></name><name><surname>van Crevel</surname><given-names>R</given-names></name><name><surname>Divangahi</surname><given-names>M</given-names></name><name><surname>Netea</surname><given-names>MG</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>β-Glucan induces protective trained immunity against <italic>Mycobacterium tuberculosis</italic> infection: a key role for IL-1</article-title><source>Cell Reports</source><volume>31</volume><elocation-id>107634</elocation-id><pub-id pub-id-type="doi">10.1016/j.celrep.2020.107634</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morrison</surname><given-names>SJ</given-names></name><name><surname>Scadden</surname><given-names>DT</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The bone marrow niche for haematopoietic stem cells</article-title><source>Nature</source><volume>505</volume><fpage>327</fpage><lpage>334</lpage><pub-id pub-id-type="doi">10.1038/nature12984</pub-id><pub-id pub-id-type="pmid">24429631</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagai</surname><given-names>Y</given-names></name><name><surname>Garrett</surname><given-names>KP</given-names></name><name><surname>Ohta</surname><given-names>S</given-names></name><name><surname>Bahrun</surname><given-names>U</given-names></name><name><surname>Kouro</surname><given-names>T</given-names></name><name><surname>Akira</surname><given-names>S</given-names></name><name><surname>Takatsu</surname><given-names>K</given-names></name><name><surname>Kincade</surname><given-names>PW</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Toll-like receptors on hematopoietic progenitor cells stimulate innate immune system replenishment</article-title><source>Immunity</source><volume>24</volume><fpage>801</fpage><lpage>812</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2006.04.008</pub-id><pub-id pub-id-type="pmid">16782035</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naik</surname><given-names>S</given-names></name><name><surname>Fuchs</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Inflammatory memory and tissue adaptation in sickness and in health</article-title><source>Nature</source><volume>607</volume><fpage>249</fpage><lpage>255</lpage><pub-id pub-id-type="doi">10.1038/s41586-022-04919-3</pub-id><pub-id pub-id-type="pmid">35831602</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakauchi</surname><given-names>H</given-names></name><name><surname>Takano</surname><given-names>H</given-names></name><name><surname>Ema</surname><given-names>H</given-names></name><name><surname>Osawa</surname><given-names>M</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Further characterization of CD34-low/negative mouse hematopoietic stem cells</article-title><source>Annals of the New York Academy of Sciences</source><volume>872</volume><fpage>57</fpage><lpage>66</lpage><pub-id pub-id-type="doi">10.1111/j.1749-6632.1999.tb08453.x</pub-id><pub-id pub-id-type="pmid">10372111</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Netea</surname><given-names>MG</given-names></name><name><surname>Domínguez-Andrés</surname><given-names>J</given-names></name><name><surname>Barreiro</surname><given-names>LB</given-names></name><name><surname>Chavakis</surname><given-names>T</given-names></name><name><surname>Divangahi</surname><given-names>M</given-names></name><name><surname>Fuchs</surname><given-names>E</given-names></name><name><surname>Joosten</surname><given-names>LAB</given-names></name><name><surname>van der Meer</surname><given-names>JWM</given-names></name><name><surname>Mhlanga</surname><given-names>MM</given-names></name><name><surname>Mulder</surname><given-names>WJM</given-names></name><name><surname>Riksen</surname><given-names>NP</given-names></name><name><surname>Schlitzer</surname><given-names>A</given-names></name><name><surname>Schultze</surname><given-names>JL</given-names></name><name><surname>Stabell Benn</surname><given-names>C</given-names></name><name><surname>Sun</surname><given-names>JC</given-names></name><name><surname>Xavier</surname><given-names>RJ</given-names></name><name><surname>Latz</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Defining trained immunity and its role in health and disease</article-title><source>Nature Reviews. Immunology</source><volume>20</volume><fpage>375</fpage><lpage>388</lpage><pub-id pub-id-type="doi">10.1038/s41577-020-0285-6</pub-id><pub-id pub-id-type="pmid">32132681</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Notta</surname><given-names>F</given-names></name><name><surname>Zandi</surname><given-names>S</given-names></name><name><surname>Takayama</surname><given-names>N</given-names></name><name><surname>Dobson</surname><given-names>S</given-names></name><name><surname>Gan</surname><given-names>OI</given-names></name><name><surname>Wilson</surname><given-names>G</given-names></name><name><surname>Kaufmann</surname><given-names>KB</given-names></name><name><surname>McLeod</surname><given-names>J</given-names></name><name><surname>Laurenti</surname><given-names>E</given-names></name><name><surname>Dunant</surname><given-names>CF</given-names></name><name><surname>McPherson</surname><given-names>JD</given-names></name><name><surname>Stein</surname><given-names>LD</given-names></name><name><surname>Dror</surname><given-names>Y</given-names></name><name><surname>Dick</surname><given-names>JE</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Distinct routes of lineage development reshape the human blood hierarchy across ontogeny</article-title><source>Science</source><volume>351</volume><elocation-id>aab2116</elocation-id><pub-id pub-id-type="doi">10.1126/science.aab2116</pub-id><pub-id pub-id-type="pmid">26541609</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ochando</surname><given-names>J</given-names></name><name><surname>Mulder</surname><given-names>WJM</given-names></name><name><surname>Madsen</surname><given-names>JC</given-names></name><name><surname>Netea</surname><given-names>MG</given-names></name><name><surname>Duivenvoorden</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Trained immunity - basic concepts and contributions to immunopathology</article-title><source>Nature Reviews. Nephrology</source><volume>19</volume><fpage>23</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1038/s41581-022-00633-5</pub-id><pub-id pub-id-type="pmid">36253509</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ogonek</surname><given-names>J</given-names></name><name><surname>Kralj Juric</surname><given-names>M</given-names></name><name><surname>Ghimire</surname><given-names>S</given-names></name><name><surname>Varanasi</surname><given-names>PR</given-names></name><name><surname>Holler</surname><given-names>E</given-names></name><name><surname>Greinix</surname><given-names>H</given-names></name><name><surname>Weissinger</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Immune reconstitution after allogeneic hematopoietic stem cell transplantation</article-title><source>Frontiers in Immunology</source><volume>7</volume><elocation-id>507</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2016.00507</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oguro</surname><given-names>H</given-names></name><name><surname>Ding</surname><given-names>L</given-names></name><name><surname>Morrison</surname><given-names>SJ</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>SLAM family markers resolve functionally distinct subpopulations of hematopoietic stem cells and multipotent progenitors</article-title><source>Cell Stem Cell</source><volume>13</volume><fpage>102</fpage><lpage>116</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2013.05.014</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orkin</surname><given-names>SH</given-names></name><name><surname>Zon</surname><given-names>LI</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Hematopoiesis: an evolving paradigm for stem cell biology</article-title><source>Cell</source><volume>132</volume><fpage>631</fpage><lpage>644</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2008.01.025</pub-id><pub-id pub-id-type="pmid">18295580</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname><given-names>AA</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Fullerton</surname><given-names>JN</given-names></name><name><surname>Boelen</surname><given-names>L</given-names></name><name><surname>Rongvaux</surname><given-names>A</given-names></name><name><surname>Maini</surname><given-names>AA</given-names></name><name><surname>Bigley</surname><given-names>V</given-names></name><name><surname>Flavell</surname><given-names>RA</given-names></name><name><surname>Gilroy</surname><given-names>DW</given-names></name><name><surname>Asquith</surname><given-names>B</given-names></name><name><surname>Macallan</surname><given-names>D</given-names></name><name><surname>Yona</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The fate and lifespan of human monocyte subsets in steady state and systemic inflammation</article-title><source>The Journal of Experimental Medicine</source><volume>214</volume><fpage>1913</fpage><lpage>1923</lpage><pub-id pub-id-type="doi">10.1084/jem.20170355</pub-id><pub-id pub-id-type="pmid">28606987</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pei</surname><given-names>W</given-names></name><name><surname>Feyerabend</surname><given-names>TB</given-names></name><name><surname>Rössler</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Postrach</surname><given-names>D</given-names></name><name><surname>Busch</surname><given-names>K</given-names></name><name><surname>Rode</surname><given-names>I</given-names></name><name><surname>Klapproth</surname><given-names>K</given-names></name><name><surname>Dietlein</surname><given-names>N</given-names></name><name><surname>Quedenau</surname><given-names>C</given-names></name><name><surname>Chen</surname><given-names>W</given-names></name><name><surname>Sauer</surname><given-names>S</given-names></name><name><surname>Wolf</surname><given-names>S</given-names></name><name><surname>Höfer</surname><given-names>T</given-names></name><name><surname>Rodewald</surname><given-names>HR</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Polylox barcoding reveals haematopoietic stem cell fates realized in vivo</article-title><source>Nature</source><volume>548</volume><fpage>456</fpage><lpage>460</lpage><pub-id pub-id-type="doi">10.1038/nature23653</pub-id><pub-id pub-id-type="pmid">28813413</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pietras</surname><given-names>EM</given-names></name><name><surname>Reynaud</surname><given-names>D</given-names></name><name><surname>Kang</surname><given-names>YA</given-names></name><name><surname>Carlin</surname><given-names>D</given-names></name><name><surname>Calero-Nieto</surname><given-names>FJ</given-names></name><name><surname>Leavitt</surname><given-names>AD</given-names></name><name><surname>Stuart</surname><given-names>JM</given-names></name><name><surname>Göttgens</surname><given-names>B</given-names></name><name><surname>Passegué</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Functionally distinct subsets of lineage-biased multipotent progenitors control blood production in normal and regenerative conditions</article-title><source>Cell Stem Cell</source><volume>17</volume><fpage>35</fpage><lpage>46</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2015.05.003</pub-id><pub-id pub-id-type="pmid">26095048</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pietras</surname><given-names>EM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Inflammation: a key regulator of hematopoietic stem cell fate in health and disease</article-title><source>Blood</source><volume>130</volume><fpage>1693</fpage><lpage>1698</lpage><pub-id pub-id-type="doi">10.1182/blood-2017-06-780882</pub-id><pub-id pub-id-type="pmid">28874349</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quintin</surname><given-names>J</given-names></name><name><surname>Saeed</surname><given-names>S</given-names></name><name><surname>Martens</surname><given-names>JHA</given-names></name><name><surname>Giamarellos-Bourboulis</surname><given-names>EJ</given-names></name><name><surname>Ifrim</surname><given-names>DC</given-names></name><name><surname>Logie</surname><given-names>C</given-names></name><name><surname>Jacobs</surname><given-names>L</given-names></name><name><surname>Jansen</surname><given-names>T</given-names></name><name><surname>Kullberg</surname><given-names>BJ</given-names></name><name><surname>Wijmenga</surname><given-names>C</given-names></name><name><surname>Joosten</surname><given-names>LAB</given-names></name><name><surname>Xavier</surname><given-names>RJ</given-names></name><name><surname>van der Meer</surname><given-names>JWM</given-names></name><name><surname>Stunnenberg</surname><given-names>HG</given-names></name><name><surname>Netea</surname><given-names>MG</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Candida albicans infection affords protection against reinfection via functional reprogramming of monocytes</article-title><source>Cell Host &amp; Microbe</source><volume>12</volume><fpage>223</fpage><lpage>232</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2012.06.006</pub-id><pub-id pub-id-type="pmid">22901542</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rathinam</surname><given-names>C</given-names></name><name><surname>Poueymirou</surname><given-names>WT</given-names></name><name><surname>Rojas</surname><given-names>J</given-names></name><name><surname>Murphy</surname><given-names>AJ</given-names></name><name><surname>Valenzuela</surname><given-names>DM</given-names></name><name><surname>Yancopoulos</surname><given-names>GD</given-names></name><name><surname>Rongvaux</surname><given-names>A</given-names></name><name><surname>Eynon</surname><given-names>EE</given-names></name><name><surname>Manz</surname><given-names>MG</given-names></name><name><surname>Flavell</surname><given-names>RA</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Efficient differentiation and function of human macrophages in humanized CSF-1 mice</article-title><source>Blood</source><volume>118</volume><fpage>3119</fpage><lpage>3128</lpage><pub-id pub-id-type="doi">10.1182/blood-2010-12-326926</pub-id><pub-id pub-id-type="pmid">21791433</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riksen</surname><given-names>NP</given-names></name><name><surname>Netea</surname><given-names>MG</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Immunometabolic control of trained immunity</article-title><source>Molecular Aspects of Medicine</source><volume>77</volume><elocation-id>100897</elocation-id><pub-id pub-id-type="doi">10.1016/j.mam.2020.100897</pub-id><pub-id pub-id-type="pmid">32891423</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rix</surname><given-names>B</given-names></name><name><surname>Maduro</surname><given-names>AH</given-names></name><name><surname>Bridge</surname><given-names>KS</given-names></name><name><surname>Grey</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Markers for human haematopoietic stem cells: The disconnect between an identification marker and its function</article-title><source>Frontiers in Physiology</source><volume>13</volume><elocation-id>1009160</elocation-id><pub-id pub-id-type="doi">10.3389/fphys.2022.1009160</pub-id><pub-id pub-id-type="pmid">36246104</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saeed</surname><given-names>S</given-names></name><name><surname>Quintin</surname><given-names>J</given-names></name><name><surname>Kerstens</surname><given-names>HHD</given-names></name><name><surname>Rao</surname><given-names>NA</given-names></name><name><surname>Aghajanirefah</surname><given-names>A</given-names></name><name><surname>Matarese</surname><given-names>F</given-names></name><name><surname>Cheng</surname><given-names>S-C</given-names></name><name><surname>Ratter</surname><given-names>J</given-names></name><name><surname>Berentsen</surname><given-names>K</given-names></name><name><surname>van der Ent</surname><given-names>MA</given-names></name><name><surname>Sharifi</surname><given-names>N</given-names></name><name><surname>Janssen-Megens</surname><given-names>EM</given-names></name><name><surname>Ter Huurne</surname><given-names>M</given-names></name><name><surname>Mandoli</surname><given-names>A</given-names></name><name><surname>van Schaik</surname><given-names>T</given-names></name><name><surname>Ng</surname><given-names>A</given-names></name><name><surname>Burden</surname><given-names>F</given-names></name><name><surname>Downes</surname><given-names>K</given-names></name><name><surname>Frontini</surname><given-names>M</given-names></name><name><surname>Kumar</surname><given-names>V</given-names></name><name><surname>Giamarellos-Bourboulis</surname><given-names>EJ</given-names></name><name><surname>Ouwehand</surname><given-names>WH</given-names></name><name><surname>van der Meer</surname><given-names>JWM</given-names></name><name><surname>Joosten</surname><given-names>LAB</given-names></name><name><surname>Wijmenga</surname><given-names>C</given-names></name><name><surname>Martens</surname><given-names>JHA</given-names></name><name><surname>Xavier</surname><given-names>RJ</given-names></name><name><surname>Logie</surname><given-names>C</given-names></name><name><surname>Netea</surname><given-names>MG</given-names></name><name><surname>Stunnenberg</surname><given-names>HG</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity</article-title><source>Science</source><volume>345</volume><elocation-id>1251086</elocation-id><pub-id pub-id-type="doi">10.1126/science.1251086</pub-id><pub-id pub-id-type="pmid">25258085</pub-id></element-citation></ref><ref id="bib95"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sawai</surname><given-names>CM</given-names></name><name><surname>Babovic</surname><given-names>S</given-names></name><name><surname>Upadhaya</surname><given-names>S</given-names></name><name><surname>Knapp</surname><given-names>DJHF</given-names></name><name><surname>Lavin</surname><given-names>Y</given-names></name><name><surname>Lau</surname><given-names>CM</given-names></name><name><surname>Goloborodko</surname><given-names>A</given-names></name><name><surname>Feng</surname><given-names>J</given-names></name><name><surname>Fujisaki</surname><given-names>J</given-names></name><name><surname>Ding</surname><given-names>L</given-names></name><name><surname>Mirny</surname><given-names>LA</given-names></name><name><surname>Merad</surname><given-names>M</given-names></name><name><surname>Eaves</surname><given-names>CJ</given-names></name><name><surname>Reizis</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Hematopoietic stem cells are the major source of multilineage hematopoiesis in adult animals</article-title><source>Immunity</source><volume>45</volume><fpage>597</fpage><lpage>609</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2016.08.007</pub-id><pub-id pub-id-type="pmid">27590115</pub-id></element-citation></ref><ref id="bib96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Säwen</surname><given-names>P</given-names></name><name><surname>Eldeeb</surname><given-names>M</given-names></name><name><surname>Erlandsson</surname><given-names>E</given-names></name><name><surname>Kristiansen</surname><given-names>TA</given-names></name><name><surname>Laterza</surname><given-names>C</given-names></name><name><surname>Kokaia</surname><given-names>Z</given-names></name><name><surname>Karlsson</surname><given-names>G</given-names></name><name><surname>Yuan</surname><given-names>J</given-names></name><name><surname>Soneji</surname><given-names>S</given-names></name><name><surname>Mandal</surname><given-names>PK</given-names></name><name><surname>Rossi</surname><given-names>DJ</given-names></name><name><surname>Bryder</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Murine HSCs contribute actively to native hematopoiesis but with reduced differentiation capacity upon aging</article-title><source>eLife</source><volume>7</volume><elocation-id>e41258</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.41258</pub-id><pub-id pub-id-type="pmid">30561324</pub-id></element-citation></ref><ref id="bib97"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shaban</surname><given-names>D</given-names></name><name><surname>Najm</surname><given-names>N</given-names></name><name><surname>Droin</surname><given-names>L</given-names></name><name><surname>Nijnik</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2025">2025</year><article-title>Hematopoietic stem cell fates and the cellular hierarchy of mammalian hematopoiesis: from transplantation models to new insights from in situ analyses</article-title><source>Stem Cell Reviews and Reports</source><volume>21</volume><fpage>28</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1007/s12015-024-10782-8</pub-id><pub-id pub-id-type="pmid">39222178</pub-id></element-citation></ref><ref id="bib98"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spangrude</surname><given-names>GJ</given-names></name><name><surname>Heimfeld</surname><given-names>S</given-names></name><name><surname>Weissman</surname><given-names>IL</given-names></name></person-group><year iso-8601-date="1988">1988</year><article-title>Purification and characterization of mouse hematopoietic stem cells</article-title><source>Science</source><volume>241</volume><fpage>58</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1126/science.2898810</pub-id></element-citation></ref><ref id="bib99"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>J</given-names></name><name><surname>Ramos</surname><given-names>A</given-names></name><name><surname>Chapman</surname><given-names>B</given-names></name><name><surname>Johnnidis</surname><given-names>JB</given-names></name><name><surname>Le</surname><given-names>L</given-names></name><name><surname>Ho</surname><given-names>YJ</given-names></name><name><surname>Klein</surname><given-names>A</given-names></name><name><surname>Hofmann</surname><given-names>O</given-names></name><name><surname>Camargo</surname><given-names>FD</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Clonal dynamics of native haematopoiesis</article-title><source>Nature</source><volume>514</volume><fpage>322</fpage><lpage>327</lpage><pub-id pub-id-type="doi">10.1038/nature13824</pub-id></element-citation></ref><ref id="bib100"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>SJ</given-names></name><name><surname>Aguirre-Gamboa</surname><given-names>R</given-names></name><name><surname>de Bree</surname><given-names>LCJ</given-names></name><name><surname>Sanz</surname><given-names>J</given-names></name><name><surname>Dumaine</surname><given-names>A</given-names></name><name><surname>van der Velden</surname><given-names>W</given-names></name><name><surname>Joosten</surname><given-names>LAB</given-names></name><name><surname>Khader</surname><given-names>S</given-names></name><name><surname>Divangahi</surname><given-names>M</given-names></name><name><surname>Netea</surname><given-names>MG</given-names></name><name><surname>Barreiro</surname><given-names>LB</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>BCG vaccination alters the epigenetic landscape of progenitor cells in human bone marrow to influence innate immune responses</article-title><source>Immunity</source><volume>57</volume><fpage>2095</fpage><lpage>2107</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2024.07.021</pub-id><pub-id pub-id-type="pmid">39153479</pub-id></element-citation></ref><ref id="bib101"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takizawa</surname><given-names>H</given-names></name><name><surname>Boettcher</surname><given-names>S</given-names></name><name><surname>Manz</surname><given-names>MG</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Demand-adapted regulation of early hematopoiesis in infection and inflammation</article-title><source>Blood</source><volume>119</volume><fpage>2991</fpage><lpage>3002</lpage><pub-id pub-id-type="doi">10.1182/blood-2011-12-380113</pub-id><pub-id pub-id-type="pmid">22246037</pub-id></element-citation></ref><ref id="bib102"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname><given-names>SJ</given-names></name><name><surname>Stauber</surname><given-names>J</given-names></name><name><surname>Bohorquez</surname><given-names>O</given-names></name><name><surname>Tatsumi</surname><given-names>G</given-names></name><name><surname>Kumari</surname><given-names>R</given-names></name><name><surname>Chakraborty</surname><given-names>J</given-names></name><name><surname>Bartholdy</surname><given-names>BA</given-names></name><name><surname>Schwenger</surname><given-names>E</given-names></name><name><surname>Sundaravel</surname><given-names>S</given-names></name><name><surname>Farahat</surname><given-names>AA</given-names></name><name><surname>Wheat</surname><given-names>JC</given-names></name><name><surname>Goldfinger</surname><given-names>M</given-names></name><name><surname>Verma</surname><given-names>A</given-names></name><name><surname>Kumar</surname><given-names>A</given-names></name><name><surname>Boykin</surname><given-names>DW</given-names></name><name><surname>Stengel</surname><given-names>KR</given-names></name><name><surname>Poon</surname><given-names>GMK</given-names></name><name><surname>Steidl</surname><given-names>U</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>Pharmacological restriction of genomic binding sites redirects PU.1 pioneer transcription factor activity</article-title><source>Nature Genetics</source><volume>56</volume><fpage>2213</fpage><lpage>2227</lpage><pub-id pub-id-type="doi">10.1038/s41588-024-01911-7</pub-id><pub-id pub-id-type="pmid">39294495</pub-id></element-citation></ref><ref id="bib103"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teh</surname><given-names>YC</given-names></name><name><surname>Ding</surname><given-names>JL</given-names></name><name><surname>Ng</surname><given-names>LG</given-names></name><name><surname>Chong</surname><given-names>SZ</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Capturing the fantastic voyage of monocytes through time and space</article-title><source>Frontiers in Immunology</source><volume>10</volume><elocation-id>834</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2019.00834</pub-id><pub-id pub-id-type="pmid">31040854</pub-id></element-citation></ref><ref id="bib104"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Puffelen</surname><given-names>JH</given-names></name><name><surname>Keating</surname><given-names>ST</given-names></name><name><surname>Oosterwijk</surname><given-names>E</given-names></name><name><surname>van der Heijden</surname><given-names>AG</given-names></name><name><surname>Netea</surname><given-names>MG</given-names></name><name><surname>Joosten</surname><given-names>LAB</given-names></name><name><surname>Vermeulen</surname><given-names>SH</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Trained immunity as a molecular mechanism for BCG immunotherapy in bladder cancer</article-title><source>Nature Reviews. Urology</source><volume>17</volume><fpage>513</fpage><lpage>525</lpage><pub-id pub-id-type="doi">10.1038/s41585-020-0346-4</pub-id><pub-id pub-id-type="pmid">32678343</pub-id></element-citation></ref><ref id="bib105"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verma</surname><given-names>D</given-names></name><name><surname>Parasa</surname><given-names>VR</given-names></name><name><surname>Raffetseder</surname><given-names>J</given-names></name><name><surname>Martis</surname><given-names>M</given-names></name><name><surname>Mehta</surname><given-names>RB</given-names></name><name><surname>Netea</surname><given-names>M</given-names></name><name><surname>Lerm</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Anti-mycobacterial activity correlates with altered DNA methylation pattern in immune cells from BCG-vaccinated subjects</article-title><source>Scientific Reports</source><volume>7</volume><elocation-id>12305</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-017-12110-2</pub-id><pub-id pub-id-type="pmid">28951586</pub-id></element-citation></ref><ref id="bib106"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walk</surname><given-names>J</given-names></name><name><surname>de Bree</surname><given-names>LCJ</given-names></name><name><surname>Graumans</surname><given-names>W</given-names></name><name><surname>Stoter</surname><given-names>R</given-names></name><name><surname>van Gemert</surname><given-names>G-J</given-names></name><name><surname>van de Vegte-Bolmer</surname><given-names>M</given-names></name><name><surname>Teelen</surname><given-names>K</given-names></name><name><surname>Hermsen</surname><given-names>CC</given-names></name><name><surname>Arts</surname><given-names>RJW</given-names></name><name><surname>Behet</surname><given-names>MC</given-names></name><name><surname>Keramati</surname><given-names>F</given-names></name><name><surname>Moorlag</surname><given-names>SJCFM</given-names></name><name><surname>Yang</surname><given-names>ASP</given-names></name><name><surname>van Crevel</surname><given-names>R</given-names></name><name><surname>Aaby</surname><given-names>P</given-names></name><name><surname>de Mast</surname><given-names>Q</given-names></name><name><surname>van der Ven</surname><given-names>AJAM</given-names></name><name><surname>Stabell Benn</surname><given-names>C</given-names></name><name><surname>Netea</surname><given-names>MG</given-names></name><name><surname>Sauerwein</surname><given-names>RW</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Outcomes of controlled human malaria infection after BCG vaccination</article-title><source>Nature Communications</source><volume>10</volume><elocation-id>874</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-019-08659-3</pub-id><pub-id pub-id-type="pmid">30787276</pub-id></element-citation></ref><ref id="bib107"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walk</surname><given-names>J</given-names></name><name><surname>Keramati</surname><given-names>F</given-names></name><name><surname>de Bree</surname><given-names>LCJ</given-names></name><name><surname>Arts</surname><given-names>RJW</given-names></name><name><surname>Blok</surname><given-names>B</given-names></name><name><surname>Netea</surname><given-names>MG</given-names></name><name><surname>Stunnenberg</surname><given-names>HG</given-names></name><name><surname>Sauerwein</surname><given-names>RW</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Controlled human malaria infection induces long-term functional changes in monocytes</article-title><source>Frontiers in Molecular Biosciences</source><volume>7</volume><elocation-id>604553</elocation-id><pub-id pub-id-type="doi">10.3389/fmolb.2020.604553</pub-id><pub-id pub-id-type="pmid">33324683</pub-id></element-citation></ref><ref id="bib108"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>T</given-names></name><name><surname>Nandakumar</surname><given-names>V</given-names></name><name><surname>Jiang</surname><given-names>XX</given-names></name><name><surname>Jones</surname><given-names>L</given-names></name><name><surname>Yang</surname><given-names>AG</given-names></name><name><surname>Huang</surname><given-names>XF</given-names></name><name><surname>Chen</surname><given-names>SY</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The control of hematopoietic stem cell maintenance, self-renewal, and differentiation by Mysm1-mediated epigenetic regulation</article-title><source>Blood</source><volume>122</volume><fpage>2812</fpage><lpage>2822</lpage><pub-id pub-id-type="doi">10.1182/blood-2013-03-489641</pub-id><pub-id pub-id-type="pmid">24014243</pub-id></element-citation></ref><ref id="bib109"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilkinson</surname><given-names>AC</given-names></name><name><surname>Ishida</surname><given-names>R</given-names></name><name><surname>Kikuchi</surname><given-names>M</given-names></name><name><surname>Sudo</surname><given-names>K</given-names></name><name><surname>Morita</surname><given-names>M</given-names></name><name><surname>Crisostomo</surname><given-names>RV</given-names></name><name><surname>Yamamoto</surname><given-names>R</given-names></name><name><surname>Loh</surname><given-names>KM</given-names></name><name><surname>Nakamura</surname><given-names>Y</given-names></name><name><surname>Watanabe</surname><given-names>M</given-names></name><name><surname>Nakauchi</surname><given-names>H</given-names></name><name><surname>Yamazaki</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Long-term ex vivo haematopoietic-stem-cell expansion allows nonconditioned transplantation</article-title><source>Nature</source><volume>571</volume><fpage>117</fpage><lpage>121</lpage><pub-id pub-id-type="doi">10.1038/s41586-019-1244-x</pub-id><pub-id pub-id-type="pmid">31142833</pub-id></element-citation></ref><ref id="bib110"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>A</given-names></name><name><surname>Laurenti</surname><given-names>E</given-names></name><name><surname>Oser</surname><given-names>G</given-names></name><name><surname>van der Wath</surname><given-names>RC</given-names></name><name><surname>Blanco-Bose</surname><given-names>W</given-names></name><name><surname>Jaworski</surname><given-names>M</given-names></name><name><surname>Offner</surname><given-names>S</given-names></name><name><surname>Dunant</surname><given-names>CF</given-names></name><name><surname>Eshkind</surname><given-names>L</given-names></name><name><surname>Bockamp</surname><given-names>E</given-names></name><name><surname>Lió</surname><given-names>P</given-names></name><name><surname>Macdonald</surname><given-names>HR</given-names></name><name><surname>Trumpp</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Hematopoietic stem cells reversibly switch from dormancy to self-renewal during homeostasis and repair</article-title><source>Cell</source><volume>135</volume><fpage>1118</fpage><lpage>1129</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2008.10.048</pub-id><pub-id pub-id-type="pmid">19062086</pub-id></element-citation></ref><ref id="bib111"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>YL</given-names></name><name><surname>Lin</surname><given-names>ZJ</given-names></name><name><surname>Li</surname><given-names>CC</given-names></name><name><surname>Lin</surname><given-names>X</given-names></name><name><surname>Shan</surname><given-names>SK</given-names></name><name><surname>Guo</surname><given-names>B</given-names></name><name><surname>Zheng</surname><given-names>MH</given-names></name><name><surname>Li</surname><given-names>F</given-names></name><name><surname>Yuan</surname><given-names>LQ</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Epigenetic regulation in metabolic diseases: mechanisms and advances in clinical study</article-title><source>Signal Transduction and Targeted Therapy</source><volume>8</volume><elocation-id>013337</elocation-id><pub-id pub-id-type="doi">10.1038/s41392-023-01333-7</pub-id></element-citation></ref><ref id="bib112"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>L</given-names></name><name><surname>Bryder</surname><given-names>D</given-names></name><name><surname>Adolfsson</surname><given-names>J</given-names></name><name><surname>Nygren</surname><given-names>J</given-names></name><name><surname>Månsson</surname><given-names>R</given-names></name><name><surname>Sigvardsson</surname><given-names>M</given-names></name><name><surname>Jacobsen</surname><given-names>SEW</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Identification of Lin–Sca1+kit+CD34+Flt3– short-term hematopoietic stem cells capable of rapidly reconstituting and rescuing myeloablated transplant recipients</article-title><source>Blood</source><volume>105</volume><fpage>2717</fpage><lpage>2723</lpage><pub-id pub-id-type="doi">10.1182/blood-2004-06-2159</pub-id></element-citation></ref><ref id="bib113"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Gomez</surname><given-names>N</given-names></name><name><surname>Infarinato</surname><given-names>N</given-names></name><name><surname>Adam</surname><given-names>RC</given-names></name><name><surname>Sribour</surname><given-names>M</given-names></name><name><surname>Baek</surname><given-names>I</given-names></name><name><surname>Laurin</surname><given-names>M</given-names></name><name><surname>Fuchs</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>The pioneer factor SOX9 competes for epigenetic factors to switch stem cell fates</article-title><source>Nature Cell Biology</source><volume>25</volume><fpage>1185</fpage><lpage>1195</lpage><pub-id pub-id-type="doi">10.1038/s41556-023-01184-y</pub-id></element-citation></ref><ref id="bib114"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>Y</given-names></name><name><surname>Jeyanathan</surname><given-names>M</given-names></name><name><surname>Haddadi</surname><given-names>S</given-names></name><name><surname>Barra</surname><given-names>NG</given-names></name><name><surname>Vaseghi-Shanjani</surname><given-names>M</given-names></name><name><surname>Damjanovic</surname><given-names>D</given-names></name><name><surname>Lai</surname><given-names>R</given-names></name><name><surname>Afkhami</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Dvorkin-Gheva</surname><given-names>A</given-names></name><name><surname>Robbins</surname><given-names>CS</given-names></name><name><surname>Schertzer</surname><given-names>JD</given-names></name><name><surname>Xing</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Induction of autonomous memory alveolar macrophages requires T cell help and is critical to trained immunity</article-title><source>Cell</source><volume>175</volume><fpage>1634</fpage><lpage>1650</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2018.09.042</pub-id><pub-id pub-id-type="pmid">30433869</pub-id></element-citation></ref><ref id="bib115"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yeung</surname><given-names>J</given-names></name><name><surname>Liao</surname><given-names>A</given-names></name><name><surname>Shaw</surname><given-names>M</given-names></name><name><surname>Silva</surname><given-names>S</given-names></name><name><surname>Vetharoy</surname><given-names>W</given-names></name><name><surname>Rico</surname><given-names>DL</given-names></name><name><surname>Kirby</surname><given-names>I</given-names></name><name><surname>Zammarchi</surname><given-names>F</given-names></name><name><surname>Havenith</surname><given-names>K</given-names></name><name><surname>de Haan</surname><given-names>L</given-names></name><name><surname>van Berkel</surname><given-names>PH</given-names></name><name><surname>Sebire</surname><given-names>N</given-names></name><name><surname>Ogunbiyi</surname><given-names>OK</given-names></name><name><surname>Booth</surname><given-names>C</given-names></name><name><surname>Gaspar</surname><given-names>HB</given-names></name><name><surname>Thrasher</surname><given-names>AJ</given-names></name><name><surname>Chester</surname><given-names>KA</given-names></name><name><surname>Amrolia</surname><given-names>PJ</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>Anti-CD45 PBD-based antibody-drug conjugates are effective targeted conditioning agents for gene therapy and stem cell transplant</article-title><source>Molecular Therapy</source><volume>32</volume><fpage>1672</fpage><lpage>1686</lpage><pub-id pub-id-type="doi">10.1016/j.ymthe.2024.03.032</pub-id><pub-id pub-id-type="pmid">38549377</pub-id></element-citation></ref><ref id="bib116"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Zeng</surname><given-names>AGX</given-names></name><name><surname>Nagree</surname><given-names>MS</given-names></name><name><surname>Jakobsen</surname><given-names>NA</given-names></name><name><surname>Shah</surname><given-names>S</given-names></name><name><surname>Murison</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>A hematopoietic stem cell subset that retains memory of prior inflammatory stress accumulates in aging and clonal hematopoiesis</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/2023.09.11.557271</pub-id></element-citation></ref><ref id="bib117"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Sun</surname><given-names>B</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Ma</surname><given-names>D</given-names></name><name><surname>Lv</surname><given-names>J</given-names></name><name><surname>Heng</surname><given-names>J</given-names></name><name><surname>Ding</surname><given-names>Y</given-names></name><name><surname>Xue</surname><given-names>Y</given-names></name><name><surname>Lu</surname><given-names>X</given-names></name><name><surname>Xiao</surname><given-names>W</given-names></name><name><surname>Yang</surname><given-names>YG</given-names></name><name><surname>Liu</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>m6A modulates haematopoietic stem and progenitor cell specification</article-title><source>Nature</source><volume>549</volume><fpage>273</fpage><lpage>276</lpage><pub-id pub-id-type="doi">10.1038/nature23883</pub-id></element-citation></ref><ref id="bib118"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Gao</surname><given-names>Q</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Cheng</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>S</given-names></name><name><surname>Xu</surname><given-names>R</given-names></name><name><surname>Yuan</surname><given-names>J</given-names></name><name><surname>Novakovic</surname><given-names>B</given-names></name><name><surname>Netea</surname><given-names>MG</given-names></name><name><surname>Cheng</surname><given-names>SC</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>Persistent bone marrow hemozoin accumulation confers a survival advantage against bacterial infection via cell-intrinsic Myd88 signaling</article-title><source>Cell Reports</source><volume>43</volume><elocation-id>114850</elocation-id><pub-id pub-id-type="doi">10.1016/j.celrep.2024.114850</pub-id><pub-id pub-id-type="pmid">39392758</pub-id></element-citation></ref><ref id="bib119"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ziogas</surname><given-names>A</given-names></name><name><surname>Novakovic</surname><given-names>B</given-names></name><name><surname>Ventriglia</surname><given-names>L</given-names></name><name><surname>Galang</surname><given-names>N</given-names></name><name><surname>Tran</surname><given-names>KA</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Matzaraki</surname><given-names>V</given-names></name><name><surname>van Unen</surname><given-names>N</given-names></name><name><surname>Schlüter</surname><given-names>T</given-names></name><name><surname>Ferreira</surname><given-names>AV</given-names></name><name><surname>Moorlag</surname><given-names>S</given-names></name><name><surname>Koeken</surname><given-names>V</given-names></name><name><surname>Moyo</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Baltissen</surname><given-names>MPA</given-names></name><name><surname>Martens</surname><given-names>JHA</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Divangahi</surname><given-names>M</given-names></name><name><surname>Joosten</surname><given-names>LAB</given-names></name><name><surname>Mhlanga</surname><given-names>MM</given-names></name><name><surname>Netea</surname><given-names>MG</given-names></name></person-group><year iso-8601-date="2025">2025</year><article-title>Long-term histone lactylation connects metabolic and epigenetic rewiring in innate immune memory</article-title><source>Cell</source><volume>188</volume><fpage>2992</fpage><lpage>3012</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2025.03.048</pub-id><pub-id pub-id-type="pmid">40318634</pub-id></element-citation></ref></ref-list></back></article>